Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E15.36 EPS (ttm)10.01 Insider Own0.13% Shs Outstand747.00M Perf Week-1.80%
Market Cap114.89B Forward P/E12.35 EPS next Y12.46 Insider Trans-0.30% Shs Float741.70M Perf Month2.97%
Income7.59B PEG2.21 EPS next Q2.79 Inst Own80.10% Short Float0.84% Perf Quarter-4.89%
Sales22.56B P/S5.09 EPS this Y35.20% Inst Trans0.10% Short Ratio1.48 Perf Half Y-4.60%
Book/sh41.20 P/B3.73 EPS next Y7.81% ROA10.10% Target Price181.73 Perf Year1.83%
Cash/sh50.84 P/C3.02 EPS next 5Y6.94% ROE25.80% 52W Range132.74 - 175.66 Perf YTD5.19%
Dividend4.60 P/FCF407.41 EPS past 5Y13.60% ROI12.50% 52W High-12.26% Beta1.15
Dividend %2.99% Quick Ratio4.10 Sales past 5Y7.60% Gross Margin81.50% 52W Low16.11% ATR2.72
Employees17900 Current Ratio4.30 Sales Q/Q1.50% Oper. Margin41.40% RSI (14)56.11 Volatility1.35% 1.56%
OptionableYes Debt/Eq1.15 EPS Q/Q9.80% Profit Margin33.60% Rel Volume0.70 Prev Close153.80
ShortableYes LT Debt/Eq0.99 EarningsFeb 02 AMC Payout37.50% Avg Volume4.21M Price154.13
Recom2.40 SMA201.38% SMA504.12% SMA200-1.76% Volume1,508,933 Change0.21%
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-04-15Initiated Wells Fargo Market Perform
Oct-29-15Reiterated UBS Buy $168 → $180
Sep-01-15Initiated Raymond James Mkt Perform
Jul-31-15Reiterated RBC Capital Mkts Outperform $185 → $190
Jul-31-15Reiterated Deutsche Bank Buy $192 → $195
Jul-31-15Reiterated Barclays Equal Weight $180 → $185
May-28-15Reiterated Deutsche Bank Buy $200 → $192
Apr-22-15Reiterated UBS Buy $175 → $185
Apr-22-15Reiterated RBC Capital Mkts Outperform $178 → $185
Oct-29-14Reiterated Argus Buy $140 → $185
Oct-28-14Reiterated RBC Capital Mkts Outperform $150 → $165
Jan-20-17 09:07AM  How Did JNJs Pharmaceuticals Segment Perform in 4Q16?
07:00AM  Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017
Jan-19-17 08:35PM  3 Stocks Ripe for a Big Rebound in 2017 at TheStreet
01:27PM  Value Investing 2017: 3 Stocks to Put on Your Radar at Motley Fool
09:55AM  Can Amgen (AMGN) Be a Top Choice for Value Investors?
09:23AM  Why Trump's Potential $500 Billion Tax Holiday Could Make Apple and Microsoft Massive Winners
Jan-18-17 04:33PM  Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen
12:12PM  Trump health pick Price defends investments, Obamacare replacement Reuters
10:40AM  Orphan Drugs Among 2015's Top 10 Best-Selling Medications
09:26AM  5 Biotech Stocks You'll Want to Watch in the 1st Quarter at Motley Fool
06:00AM  Trump's health pick set to defend investments at U.S. Senate hearing Reuters
Jan-17-17 04:43PM  Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad
10:00AM  deCODE Study Shows that Variants in the Sequence of the Genome that Contribute to Educational Attainment are Under Negative Selection PR Newswire
07:10AM  Better Buy: Amgen Inc. vs. Celgene Corporation at Motley Fool
Jan-13-17 04:32PM  Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink
04:16PM  Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
03:52PM  [$$] Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs at The Wall Street Journal
02:44PM  Supreme Court to hear a variety of business-related to ca...
02:33PM  Amgen Fight Over Copies of Biotech Drugs Gets High Court Review at Bloomberg
Jan-12-17 05:10PM  Trumps HHS nominee has promised to divest from these Mass. companies at bizjournals.com
03:22PM  Investors in big pharma, biotech look to ride out Trump storm
01:23PM  Amgen, Inc. : AMGN-US: Dividend Analysis : November 16th, 2016 (record date) : By the numbers : January 12, 2017
11:56AM  [$$] Sanofi confident it can overturn Praluent patent ruling at Financial Times
09:35AM  Biotech Short Sellers Run for Cover
08:40AM  3 Cheap Value Stocks to Buy Today at Motley Fool
07:32AM  5 Things You Must Know Before the Market Opens Thursday
Jan-11-17 01:59PM  Trump's Comments Slam Drug Stocks at The Wall Street Journal
09:13AM  Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
08:24AM  Amgen: Phase III Data on Hyperparathyroidism Drug Published
Jan-10-17 04:12PM  Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis PR Newswire
03:23PM  Why Amgen's Stock Slumped in 2016 at Motley Fool
08:51AM  Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan-09-17 08:48PM  Regeneron CEO says Amgen not putting patients first in patent dispute Reuters
06:21PM  Amgen Statement on January 9, 2017, U.S. District Court Decision PR Newswire
05:41PM  So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
02:59PM  Stocks Still Mixed, Medicals Lead Upside; Is Incyte The Next Amgen?
01:33PM  Bullish and Bearish Reversals in the Market
01:30PM  Morgan Stanley Cuts Regeneron Target On Praluent Patent Worries at Barrons.com
08:45AM  Amgen Launches Cancer Partnership With Immatics at Investopedia
08:15AM  Blog Coverage Amgen's Legal Victory Blocks Rivals Sanofi and Regeneron from Selling their Cholesterol Drug in the US Accesswire
08:14AM  5 Rocket Stocks for 2017 -- Amgen, eBay, More
06:12AM  AMGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreem
06:00AM  Amgen And DaVita Enter Into New Sourcing And Supply Agreement PR Newswire
04:00AM  Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies PR Newswire
Jan-08-17 11:54PM  [$$] Regeneron Is Down, Not Out at The Wall Street Journal
02:02PM  Why Biotech Titans Are Clashing Over Cholesterol at Motley Fool
Jan-07-17 10:47AM  Judges unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake at MarketWatch
Jan-06-17 08:09PM  Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
07:33PM  Sanofi Investors Count Cost of Praluent Ruling at The Wall Street Journal
06:41PM  Why Regeneron Pharmaceuticals, Sears Holdings, and Shake Shack Slumped Today at Motley Fool
06:35PM  The Biggest Loser: Regeneron Sinks 5.8% at Barrons.com
06:16PM  Cramer's game plan: Banks will be in hog heaven next week at CNBC
05:00PM  Stocks to buy near Dow 20K: 4 trades
04:56PM  [$$] Amgen Patent Win Boosts Odds of a Stock Comeback at Barrons.com
04:40PM  Higher wages push stocks to records, but Dow misses 20,000
04:22PM  Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?
04:13PM  Regeneron, Sanofi Hammered After Judge Bans Amgen-Rivaling LDL-Buster
03:52PM  [$$] Amgen Takes Stake in New Partner SiteOne at The Wall Street Journal
03:04PM  The C-Suite Braces for the Trump Era
02:12PM  Regeneron: Let's Make a Deal? at Barrons.com
02:10PM  Rally will fade away into second half: Analyst
01:59PM  Sanofi Counts Cost of Ruling That Blocks Its Cholesterol Drug at The Wall Street Journal
01:23PM  [$$] Regeneron Is Down, Not Out at The Wall Street Journal
12:57PM  Regeneron shares fall after judge blocks selling of cholesterol-lowering drug at CNBC
11:55AM  Fridays 6 Biopharma Movers That Cant Be Ignored
11:47AM  [$$] Regeneron shares tumble as US court blocks cholesterol drug at Financial Times
11:45AM  Amgen Set to Test Two Year Range Resistance (AMGN) at Investopedia
11:28AM  US STOCKS-S&P, Dow flat after jobs data; tech stocks lift Nasdaq
10:28AM  Could Amgen's Patent Victory Be Bad For Medicine? at Forbes
10:16AM  Regeneron, Sanofi Cholesterol Drug Gets Blocked at Investopedia
10:13AM  Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View
10:04AM  Gap soars on holiday sales cheer, Amgen jumps on patent win, Apple to open store in Samsung's home turf
09:56AM  US STOCKS-Wall St loses ground after mixed jobs data
09:40AM  Stock Open Lower After Jobs Report; Early Risers: Amgen, Ionis, Stemline
09:07AM  What Were Incytes Revenue Streams in 3Q16?
08:18AM  Regeneron Cholesterol-Lowering Drug Banned From U.S. Market at TheStreet
08:13AM  Amgen Establishes a Bottom and Signals It's Time to Buy
07:45AM  Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent
06:13AM  U.S. stock futures tread water ahead of jobs report at MarketWatch
05:53AM  Sanofi Investors Have Worst Day in Six Months
05:53AM  5 Things You Must Know Before the Market Opens Friday
05:50AM  Regeneron Cholesterol-Lowering Drug Banned From U.S. Market in Stunning Loss to Amgen in Patent Case
12:08AM  [$$] Judge Rules Against Sanofi and Regeneron in Patent Case at The Wall Street Journal
Jan-05-17 09:34PM  Court Grants Permanent Injunction For Infringement Of Amgen's Repatha Patents PR Newswire
08:37PM  [$$] Judge Rules Against Sanofi and Regeneron in Patent Case at The Wall Street Journal
06:09PM  Amgen shares soar as judge blocks sales of Regeneron drug at MarketWatch
05:57PM  After-hours buzz: GPS, AMGN, SHAK & more at CNBC
05:52PM  Sanofi, Regeneron blocked from selling cholesterol drug
05:18PM  After Hours: Gap Gaps Up, Amgen Blocks Rival, Shake Shack Shakeup
04:51PM  Why the rising price of overdose antidotes?
04:46PM  Amgen Wins Ban on Sanofis Praluent Cholesterol Drug Sales at Bloomberg
12:36PM  Senate Dems, D.C. Watchdog Call for Investigation Into Trump HHS Pick Tom Price's Stock Portfolio
09:30AM  The Zacks Analyst Blog Highlights: Comcast, Amgen, General Mills, Target and Ford
08:52AM  This is how an investor turned around a once-venerable mutual fund at MarketWatch
Jan-04-17 04:09PM  Regeneron, Sanofi LDL-Buster At Risk After Judge Upholds Amgen Patents
04:00PM  Amgen To Present At The 35th Annual J.P. Morgan Healthcare Conference PR Newswire
02:30PM  Amgen Keeps Cholesterol Drug Patent Vs Regeneron at Investopedia
12:20PM  Stock Research Reports for Comcast, Amgen & General Mills
11:06AM  Regeneron: Who Cares If Amgen Won the Latest Patent Battle? at Barrons.com
09:21AM  These 3 Dividend Stocks Are Ridiculously Cheap at Motley Fool
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Neulasta, a pegylated protein for the treatment of cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. Its products also comprise EPOGEN to treat a lower-than-normal number of red blood cells caused by chronic kidney disease (CKD) in patients on dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; Repatha for the treatment of cholesterol; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. The company's other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with Xencor, Inc; UCB; Novartis AG; Bayer HealthCare Pharmaceuticals Inc; Advaxis, Inc.; Dr. Reddy's Laboratories Ltd.; Biocartis Group NV; and Nuevolution AB. The company also has a strategic collaboration with Immatics Biotechnologies GmbH. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Carbonnel FrancoisDirectorSep 09Option Exercise71.645,000358,20021,171Sep 13 06:21 PM
Such Annette LouiseVP, Finance and CAOAug 02Sale174.593,000523,7587,183Aug 03 08:14 PM
Balachandran MadhavanEVP, OperationsMay 04Sale154.1230,0004,623,62455,996May 05 08:16 PM
BALTIMORE DAVIDDirectorApr 29Sale157.213,312520,68432,350May 03 07:12 PM
BALTIMORE DAVIDDirectorMar 30Option Exercise50.445,000252,20037,350Mar 31 06:01 PM
HERRINGER FRANK CDirectorMar 14Option Exercise50.445,000252,20030,608Mar 16 06:48 PM
COFFMAN VANCE DDirectorMar 09Option Exercise50.445,000252,20043,447Mar 10 06:55 PM
Bradway Robert AChairman, CEO and PresidentMar 02Option Exercise50.4484,0004,236,960447,102Mar 04 06:07 PM
Bradway Robert AChairman, CEO and PresidentMar 02Sale146.4820,0002,929,566383,102Mar 04 06:07 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E21.29 EPS (ttm)4.99 Insider Own0.10% Shs Outstand829.00M Perf Week1.89%
Market Cap88.07B Forward P/E18.98 EPS next Y5.60 Insider Trans-6.99% Shs Float821.94M Perf Month2.84%
Income4.21B PEG3.15 EPS next Q1.33 Inst Own79.60% Short Float1.04% Perf Quarter10.50%
Sales19.98B P/S4.41 EPS this Y-4.50% Inst Trans0.05% Short Ratio1.96 Perf Half Y14.21%
Book/sh24.47 P/B4.34 EPS next Y11.76% ROA7.60% Target Price106.75 Perf Year48.02%
Cash/sh2.70 P/C39.34 EPS next 5Y6.76% ROE20.50% 52W Range65.39 - 108.98 Perf YTD2.47%
Dividend2.42 P/FCF62.64 EPS past 5Y14.70% ROI14.80% 52W High-1.84% Beta0.71
Dividend %2.28% Quick Ratio1.20 Sales past 5Y5.20% Gross Margin81.10% 52W Low63.60% ATR2.15
Employees43154 Current Ratio1.40 Sales Q/Q-7.00% Oper. Margin36.20% RSI (14)63.73 Volatility2.15% 1.80%
OptionableYes Debt/Eq0.77 EPS Q/Q-9.50% Profit Margin21.00% Rel Volume1.28 Prev Close106.24
ShortableYes LT Debt/Eq0.75 EarningsJan 19 BMO Payout43.90% Avg Volume4.37M Price106.97
Recom2.30 SMA202.72% SMA504.91% SMA20016.01% Volume2,861,605 Change0.69%
Jan-20-17Reiterated RBC Capital Mkts Sector Perform $111 → $115
Jan-20-17Reiterated Cowen Market Perform $98 → $109
Jan-18-17Initiated Buckingham Research Neutral
Jan-09-17Upgrade Barclays Equal Weight → Overweight $104 → $122
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-24-16Initiated Seaport Global Securities Buy $100
Oct-21-16Downgrade RBC Capital Mkts Outperform → Sector Perform $107 → $98
Oct-20-16Downgrade Cowen Outperform → Market Perform $99 → $91
Jul-20-16Downgrade Deutsche Bank Buy → Hold $94
Jun-03-16Upgrade Morgan Stanley Equal-Weight → Overweight $90
May-19-16Initiated Credit Agricole Sell
Apr-22-16Reiterated RBC Capital Mkts Outperform $90 → $95
Apr-18-16Downgrade UBS Buy → Neutral $89 → $88
Feb-23-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-22-16Upgrade BofA/Merrill Neutral → Buy
Jan-25-16Reiterated Argus Buy $110 → $80
Jan-22-16Reiterated Stifel Buy $95 → $78
Jan-22-16Reiterated RBC Capital Mkts Outperform $93 → $82
Jan-22-16Reiterated Deutsche Bank Buy $93 → $87
Jan-21-16Reiterated Cowen Outperform $95 → $89
Jan-20-17 11:17AM  Union Pacific Corp. :UNP-US: Earnings Analysis: Q4, 2016 By the Numbers : January 20, 2017
07:38AM  Why CSXs Merchandise Revenue Rose in 4Q16
07:08AM  Today's Top Supply Chain and Logistics News From WSJ at The Wall Street Journal
12:19AM  [$$] Business Watch at The Wall Street Journal
Jan-19-17 07:01PM  Cramer: The 3 Rail Stocks Are Sells, but That's Not the Real Story
06:41PM  Edited Transcript of UNP earnings conference call or presentation 19-Jan-17 1:45pm GMT
06:35PM  CSX shares jump 20 pct as activist reignites rail merger hopes
04:51PM  Union Pacific cost cuts offset declining shipments in 4Q
03:52PM  Union Pacific Corp. (UNP) Up on Q4 Earnings Beat
03:26PM  CSXs 4Q16 Earnings Beat Analysts Estimates, But It Fell 3.2%
03:10PM  US STOCKS-Wall St falls as investors ready for Trump's inauguration
12:49PM  US STOCKS-Wall St dips as investors ready for Trump's inauguration
12:38PM  Stocks Dip Ahead Of Inauguration, But Netflix, Tesla, Railroads Climb
12:07PM  Union Pacific CEO- "we are opposed to" major railroad mergers
11:40AM  CSX: This Train Has Left the Station at Barrons.com
11:35AM  US STOCKS-Wall St slips as countdown to Trump's swearing-in begins
10:45AM  Union Pacific Upside May be Limited at Investopedia
10:35AM  A Closer Look at Canadian Pacifics Intermodal Volume Growth
10:31AM  Railroad stocks rally as CSX poised for best gains in 36 years at MarketWatch
10:25AM  US stock indexes still treading water; bond yields climb
10:12AM  Union Pacific Shares Rise After Fourth-Quarter Profit Beats Expectations
10:06AM  CSX Jumps After Activists Team to Target Railroad -- Plus Jim Cramer's Take
09:50AM  US STOCKS-Wall St flat as countdown to Trump's swearing-in begins
09:45AM  Union Pacific profit beats estimates, "optimistic" about 2017
09:42AM  Union Pacific (UNP) Beats on Q4 Earnings
09:38AM  [$$] Union Pacific Boosted by Easing Commodities Slump at The Wall Street Journal
09:06AM  Whats Driving the Decline in Canadian Pacifics Carloads?
08:15AM  Post Earnings Coverage as CSX Revenue Climbed 9% Driven by Extra Week Accesswire
08:10AM  Union Pacific quarterly profit rises
08:04AM  UNION PACIFIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
08:00AM  Union Pacific Reports Fourth Quarter and Full Year 2016 Results PR Newswire
07:17AM  Market Recon: Interest Rates, Inflation Take Center Stage
07:07AM  Q4 2016 Union Pacific Corp Earnings Release - Before Market Open
05:59AM  5 Things You Must Know Before the Market Opens Thursday
Jan-18-17 07:38PM  Ten Dividend Stocks To Own Forever And Get Rich Slowly at Forbes
06:57PM  Trump Treasury pick Mnuchin comments could be important for dollar Thursday at CNBC
04:30PM  5 Stocks to Watch that Report Earnings Tomorrow
01:36PM  Business events scheduled for Thursday
01:24PM  Jim Cramer Is Avoiding Union Pacific Ahead of Earnings
12:31PM  Jim Cramer Previews Union Pacific's Earnings at TheStreet
10:06AM  Norfolk Southern (NSC) Q4 Earnings: What Lies in Store?
09:08AM  How Is CSXs Intermodal Traffic Lining Up with the Industry?
09:00AM  10 Best Dividend Stocks of the Dow at Kiplinger
08:20AM  CSX Corporation (CSX) Beats on Q4 Earnings and Revenues
06:45AM  Coverage initiated on Union Pacific by Buckingham Research
Jan-17-17 09:21PM  CSX's Miserable Earnings Just Ruined the Red-Hot Railroad Trade
05:35PM  These Volumes Just Pulled Down Union Pacifics Carloads
04:05PM  How Do Norfolk Southerns Carloads Compare to Other US Railroads?
02:14PM  How Are Union Pacifics Intermodal Volumes Faring among Other US Railroads?
02:14PM  Will 2017 Be a Turnaround Year for US Freight Rail Traffic?
01:01PM  Why Railroad Stocks Won't Run You Over This Earnings Season
08:44AM  Canadian National (CNI) Q4 Earnings: Is a Beat in Store?
08:27AM  Mixed Earnings Expectations For Transportation Giants
Jan-16-17 08:49AM  Railroad Stocks Q4 Earnings Reports this Week: UNP, CSX, KSU
07:37AM  Why Most Analysts Still Rate Union Pacific a Buy
Jan-13-17 06:16PM  Cramer's game plan: All eyes on the cheapest stock of the Dow at CNBC
06:13PM  Union Pacific (UNP) Q4 Earnings: What Awaits the Stock?
04:35PM  Why Union Pacifics 4Q16 Margins Might Be Its Achilless Heel
03:06PM  Can Union Pacific Meet Analysts Revenue Estimates in 4Q16?
01:34PM  Union Pacific Stock and Its Pre-4Q16 Performance
Jan-12-17 10:37AM  Will Kansas City Southern Beat 4Q16 Revenue Estimates?
08:00AM  Union Pacific Corporation Invites You to Join Its 4th Quarter 2016 Earnings Release Broadcast PR Newswire
07:37AM  How Do Analysts View CSX Corporation ahead of Its 4Q16 Results?
Jan-11-17 08:52AM  Union Pacific CEO says he's 'optimistic' about Trump and trade at CNBC
08:15AM  Post Earnings Coverage as Greenbrier's Q1 Revenues Beat Forecasts Accesswire
07:35AM  Which Commodity Groups Pulled Down Canadian Pacifics Carloads?
Jan-10-17 10:36AM  Double-Digit Rise in Volumes Minus Coal Pushed CNIs Carloads Up
10:25AM  Airlines Lead Industrial Sector Winners After Bank of America Upgrades Alaska Air
09:06AM  Rise in Container Volumes Boosts Union Pacifics Intermodal Volumes
07:37AM  Comparing CSXs Intermodal Volumes with US Railroads
Jan-09-17 10:38AM  Expansion in Coal Volumes Lifts Union Pacifics Carloads
09:07AM  Fall in Volumes Minus Coal Pulled Down Norfolk Southerns Carloads
07:37AM  Rail Traffic in the US, Canada, and Mexico Closed 2016 on an Up Note
Jan-07-17 11:28AM  Is There Any Growth Left for Union Pacific Corporation's Stock in 2017? at Motley Fool
Jan-04-17 09:30AM  Zacks Industry Outlook Highlights: Union Pacific, Canadian Pacific, Canadian National Railway, Kansas City Southern and Norfolk Southern
09:30AM  Zacks Industry Outlook Highlights: Kansas City Southern, Norfolk Southern, Canadian National Railways, Union Pacific and CSX
Jan-03-17 02:20PM  Kansas City Southern (KSU) Tumbles After Ford Junks Mexico Plant Plans
02:16PM  Union Pacific May Underwhelm; Here's How to Trade It
10:36AM  Canadian Pacifics Carloads Rise on Par with Industry Volumes
Jan-02-17 09:07AM  How Have Union Pacifics Intermodal Volumes Compared with the Industry?
07:37AM  Union Pacifics Carloads Rise Despite decline in Coal Volumes
Dec-30-16 06:05PM  Positive Coal Volumes Put Norfolk Southerns Carloads on Track
04:17PM  Double-Digit Growth in US Rail Traffic Drives Volumes into Green Zone
09:30AM  Zacks Industry Outlook Highlights: Canadian National Railways, Norfolk Southern, CSX, Union Pacific and Kansas Southern
Dec-29-16 04:20PM  Feds, Union Pacific strike deal to boost oil train safety standards at bizjournals.com
Dec-28-16 04:50PM  Tom Russo's Best Investments of the Year
10:09AM  [video]10 Grade-A Dividend Growth Stocks Worth Buying for 2017
Dec-27-16 10:36AM  Drop in Volumes Weighs On Canadian Pacifics Carloads
09:06AM  Fall in Coal Volumes Pulls down Canadian Nationals Carloads
07:36AM  Kansas City Southerns Intermodal Volumes Surprise
Dec-26-16 10:36AM  Comparing CSXs Intermodal Volumes with the Industrys
09:07AM  Higher Container Volumes Boost Union Pacifics Intermodal Volumes
07:37AM  Carloads Volume: Union Pacific versus BNSF Railway
07:36AM  Why Did FedExs Fiscal 2Q17 Operating Margins Meet with Stormy Weather?
Dec-23-16 04:31PM  APNewsBreak: Railroad in fiery derailment agrees to changes
04:02PM  Intermodal Shines in US Freight Rail Volumes, Railcars Down
01:22PM  The Latest: Railroads rack up $15 million in 2016 penalties
07:53AM  Union Pacific (UNP) Well Poised for Growth Amid Coal Woes
Dec-21-16 10:36AM  Rise in Coal Volumes Failed to Push Canadian Pacifics Carloads
09:30AM  The Zacks Analyst Blog Highlights: AbbVie, Union Pacific, U.S. Bancorp, Baker Hughes and Southwest Airlines
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers freight transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal and petroleum coke; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export containers and trailers. Union Pacific Corporation's rail network includes 32,084 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and eastern United States gateways. The company was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCCONNELL MICHAEL WDirectorDec 09Option Exercise24.257,400179,45026,410Dec 12 10:56 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Option Exercise39.1327,0681,059,287234,784Dec 12 03:30 PM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Sale104.9423,1982,434,398222,062Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Sale105.157,400778,11919,010Dec 12 10:56 AM
ROGEL STEVEN RDirectorNov 22Option Exercise24.257,400179,45011,400Nov 23 10:51 AM
ROGEL STEVEN RDirectorNov 22Sale100.517,400743,7474,000Nov 23 10:51 AM
DUREN DIANE KEVP CHIEF ADMIN OFFICER & CORPNov 18Sale98.982,840281,103128,701Nov 21 02:14 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Option Exercise66.006,484427,94471,320Oct 11 08:58 AM
Scott Cameron AEVP & CHIEF OPERATING OFFICEROct 07Sale98.446,484638,28564,836Oct 11 08:58 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 07Sale97.005,000485,00032,723Sep 09 11:09 AM
KNIGHT ROBERT M JREVP & CHIEF FINANCIAL OFFICERSep 01Sale95.2410,000952,41537,723Sep 02 03:51 PM
DUREN DIANE KEVP & CORPORATE SECRETARYJun 03Sale85.462,500213,650131,541Jun 06 12:25 PM
HOPE RICHARDS JUDITHDirectorMar 11Option Exercise24.257,400179,45031,940Mar 14 11:35 AM
HOPE RICHARDS JUDITHDirectorMar 11Sale81.154,000324,60427,940Mar 14 11:35 AM
Card Andrew H JRDirectorFeb 25Buy78.981,00078,98015,000Feb 25 05:20 PM
ROGEL STEVEN RDirectorJan 25Option Exercise21.528,400180,76812,400Jan 26 12:48 PM
ROGEL STEVEN RDirectorJan 25Sale69.448,400583,2974,000Jan 26 12:48 PM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E15.85 EPS (ttm)17.69 Insider Own0.10% Shs Outstand219.88M Perf Week-2.35%
Market Cap61.64B Forward P/E13.34 EPS next Y21.02 Insider Trans-13.35% Shs Float216.61M Perf Month-2.11%
Income3.89B PEG1.69 EPS next Q4.98 Inst Own88.40% Short Float0.96% Perf Quarter-4.98%
Sales11.42B P/S5.40 EPS this Y24.00% Inst Trans0.01% Short Ratio1.17 Perf Half Y6.84%
Book/sh55.36 P/B5.06 EPS next Y4.07% ROA18.50% Target Price341.12 Perf Year4.08%
Cash/sh19.63 P/C14.28 EPS next 5Y9.36% ROE36.00% 52W Range223.02 - 333.65 Perf YTD-1.14%
Dividend- P/FCF18.93 EPS past 5Y31.30% ROI23.50% 52W High-16.02% Beta0.72
Dividend %- Quick Ratio2.80 Sales past 5Y17.90% Gross Margin87.50% 52W Low25.64% ATR6.64
Employees7350 Current Ratio3.20 Sales Q/Q6.40% Oper. Margin47.60% RSI (14)35.27 Volatility1.68% 2.19%
OptionableYes Debt/Eq0.54 EPS Q/Q13.40% Profit Margin34.00% Rel Volume0.66 Prev Close280.35
ShortableYes LT Debt/Eq0.54 EarningsJan 26 BMO Payout0.00% Avg Volume1.78M Price280.21
Recom2.10 SMA20-2.84% SMA50-5.45% SMA200-2.00% Volume596,105 Change-0.05%
Dec-29-16Reiterated Raymond James Strong Buy $375 → $386
Dec-09-16Reiterated Stifel Hold $291 → $298
Nov-08-16Initiated Mizuho Buy $290
Nov-07-16Upgrade Piper Jaffray Neutral → Overweight
Nov-07-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-16Downgrade Jefferies Buy → Hold
Jun-29-16Initiated Bernstein Outperform
Jun-07-16Downgrade Citigroup Buy → Neutral
Feb-25-16Initiated Citigroup Buy $345
Jan-20-16Initiated Credit Suisse Neutral
Jan-07-16Initiated Standpoint Research Buy $360
Dec-04-15Resumed Wells Fargo Outperform
Oct-22-15Reiterated H.C. Wainwright Buy $380 → $360
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $400
Aug-11-15Initiated H.C. Wainwright Buy $380
Jul-27-15Upgrade Bernstein Mkt Perform → Outperform $436 → $385
Jul-27-15Reiterated RBC Capital Mkts Outperform $525 → $450
Jul-27-15Reiterated Argus Buy $450 → $360
Jul-27-15Downgrade Robert W. Baird Outperform → Neutral $480 → $316
Jan-19-17 04:34PM  Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump
02:27PM  Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst
01:06PM  Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump
11:45AM  Biogen and Siemens Healthineers Ink MS MRI Deal at Investopedia
08:40AM  Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan-18-17 04:33PM  Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen
01:04PM  BIOGEN INC. Financials
12:46PM  Biogen Inc. -- Moody's: Biogen's settlement with Forward Pharma is credit negative at Moody's
12:37PM  Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
09:30AM  The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and Berkshire Hathaway
08:40AM  Biogen to Pay $1.25B to Forward Pharma in Patient Suit at Investopedia
08:29AM  Why Forward Pharma A/S Stock Gained 48.2% on Tuesday at Motley Fool
08:15AM  Blog Coverage Benitec Biopharma Secures Orphan Drug Designation for its Product Treating Patients with Oculopharyngeal Muscular Dystrophy Accesswire
08:02AM  Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit
12:17AM  [$$] Biogens Pricey Anxiety Cure Worth Every Penny at The Wall Street Journal
Jan-17-17 05:23PM  Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today at Motley Fool
05:09PM  Biogen Resolves Multiple Sclerosis Drug Dispute at TheStreet
05:08PM  Biogen's Multiple Sclerosis Franchise to Drive Growth in 2017
04:14PM  Biogen Pays Forward Pharma $1.25 Billion To Settle Tecfidera Suit
04:01PM  Biogen Fourth Quarter and Year End 2016 Financial Results Webcast Adjusted to 8:00 am on January 26, 2017 Business Wire
12:04PM  [$$] Biogen's Pricey Anxiety Cure Worth Every Penny at The Wall Street Journal
12:00PM  Forward Pharma Shares Jump on Biogen License Agreement
11:36AM  Top Research Reports for Microsoft, Biogen & Home Depot
11:05AM  Tuesdays Top Biopharma Movers
10:46AM  Biogens $1.25 billion agreement with Forward Pharma is a very expensive insurance policy on its most valuable drug at MarketWatch
10:30AM  Siemens Healthineers and Biogen Announce Agreement to Jointly Develop New MRI Tools for Multiple Sclerosis Business Wire
10:05AM  Biogen to pay $1.25B settlement in multiple sclerosis drug case at bizjournals.com
09:45AM  [$$] Biogen Reaches Settlement and License Agreement for MS Drug at The Wall Street Journal
07:52AM  Forward Pharma stock skyrockets 53% on $1.25 bln cash licensing agreement with Biogen at MarketWatch
07:39AM  BIOGEN INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Ex
07:30AM  Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement Business Wire
04:49AM  New and Returning Bio-Tech Stock Picks for 2017 at Investopedia
Jan-16-17 09:45AM  Biogen Says Spinraza Drug Did Well In Phase 3 Trial at Investopedia
09:30AM  The Zacks Analyst Blog Highlights: Alibaba, Costco, Walgreens Boots, Biogen and PayPal
07:41AM  Biogen (BIIB) Presents Positive Phase III Data on Spinraza
Jan-13-17 06:39PM  Is Biogen's Stock Ready to Heat Up After a Forgettable 2016? at Motley Fool
02:20PM  Biogen's latest drug may be costly, but new data suggests it saves lives at bizjournals.com
01:32PM  Top Research Reports for Alibaba, Costco & Walgreens
10:16AM  Biogen Spinoff Bioverativ In Good Shape for Launch at Investopedia
09:55AM  Ionis Has High Hopes for Heart Drug Volanesorsen at Investopedia
08:31AM  Bioverativ Makes Splash in Trading Debut, Gaining 18% on Day One
07:30AM  New Data Show SPINRAZA (nusinersen) Significantly Reduces Risk of Death or Permanent Ventilation in Infantile-Onset Spinal Muscular Atrophy Business Wire
Jan-12-17 05:10PM  Trumps HHS nominee has promised to divest from these Mass. companies at bizjournals.com
09:35AM  Biotech Short Sellers Run for Cover
08:00AM  Biogen Spin-off Bioverativ Commences When-Issued Trading of Common Stock Business Wire
Jan-11-17 06:38PM  Choppy Day As Trump Targets Pharma, Lockheed; Netflix, Amazon Up
01:59PM  Trump's Comments Slam Drug Stocks at The Wall Street Journal
01:25PM  Trump slams drug industry at press conference, sending biotech stocks tumbling at bizjournals.com
01:23PM  The 1 Biotech Stock I Want to Own in 2017 at Motley Fool
10:27AM  Biogen, Inc. Value Analysis (NASDAQ:BIIB) : January 11, 2017
Jan-10-17 12:59PM  Todd Hagopian's Top Biotech Takeover Targets For 2017 at Forbes
11:54AM  3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock at Motley Fool
11:01AM  Biogen CEO Vounatsos on Drug Pipeline, Pricing
09:39AM  Top Stocks to Buy Now That the 21st Century Cures Act Has Passed at Motley Fool
07:26AM  Biogen, Inc. breached its 50 day moving average in a Bullish Manner : BIIB-US : January 10, 2017
Jan-09-17 01:01PM  This Could Very Well Be the Greatest Drug Advancement in a Decade at Motley Fool
Jan-08-17 02:00PM  3 Takeover Candidates in the Drug Space
Jan-06-17 07:25PM  Biogen's New CEO: Lots of Questions, Few Answers at Motley Fool
07:21PM  Biotech icon George Scangos returns to Bay Area with big startup at bizjournals.com
10:55AM  Biotech Investing: 3 Bold Predictions for 2017 at Motley Fool
09:07AM  What Were Incytes Revenue Streams in 3Q16?
08:32AM  Biogen Licenses Amunix's XTEN Technology for Factor IX Drug
07:05AM  New Biogen CEO explains hefty price tag for newest drug at bizjournals.com
Jan-05-17 04:55PM  5 Slides Every Ionis Pharmaceuticals Inc Investor Needs to See at Motley Fool
02:40PM  Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference at bizjournals.com
12:43PM  Drug Price Debate May Lead to Smaller Price Hikes at Investopedia
12:30PM  Biogen exercises option to enter into exclusive, worldwide License Agreement for Factor IX utilizing Amunix' XTEN(R) half-life extension technology Marketwired
11:04AM  Warning: Sell-Side Analyst Call on Failed Ionis-Biogen Drug Causes Projectile Vomiting
06:54AM  Is Biogen Playing With Fire? at Motley Fool
06:21AM  What Biotech Investors Can Expect from the J.P. Morgan Healthcare Conference 2017
Jan-04-17 05:19PM  Buy health care despite Obamacare battle?
11:55AM  Did Biogen Just Throw in the Towel to Celgene? at Motley Fool
10:57AM  Biogen, Ionis Under Fire for Pricey Drug Spinraza at Investopedia
07:21AM  Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation
Jan-03-17 05:41PM  My Worst Predictions for Biotech in 2016 at Motley Fool
02:42PM  New year, new drug prices
01:30PM  Biogen boosts price of top MS drugs, analyst says at bizjournals.com
06:35AM  17 Thoughts on Biotech Stocks to Kick Off 2017
Jan-02-17 11:54AM  Biotech Stocks: What to Watch in 2017 at Motley Fool
Dec-30-16 04:16PM  Gilead Sciences Valuation Compared to Its Peers
12:45PM  Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
09:23AM  Hemispherx BioPharma CEO Explains Chronic Fatigue Syndrome And How The Company Is Treating It
06:59AM  Extremely expensive Biogen rare disease drug could invite tweet by President-elect Trump, analyst says at MarketWatch
Dec-29-16 04:09PM  Investors Siphon Biogen, Ionis Gains After Spinal Disease Drug's OK
04:07PM  Texas Instruments A Buy; Biogen, 21st Century Fox PTs Hiked at Investor's Business Daily
01:23PM  Red flag over Biogen's very expensive drug
10:10AM  Analyst hikes sales estimates for Biogens spinal-disease drug at bizjournals.com
10:03AM  Biogen: Starting the New Year Off With a Bang? at Barrons.com
Dec-28-16 05:39PM  Why Twilio, Northern Dynasty Minerals, and Ionis Pharmaceuticals Slumped Today at Motley Fool
05:22PM  Will Spinraza Supercharge Biogen's Top Line Next Year? at Motley Fool
01:43PM  Biogen Could Suffer Near Term as the Chart Picture Erodes
10:10AM  Biotech Short Interest Sinks
07:32AM  Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold
07:23AM  The 3 Biggest Risks for Pfizer in 2017 at Motley Fool
06:52AM  Biotech plays for the new year
Dec-27-16 11:43PM  [$$] Surprise Drug Approval Is Holiday Gift for Biogen at The Wall Street Journal
03:53PM  3 Biggest Risks for AbbVie in 2017 at Motley Fool
02:45PM  Time for biotech to boom ... or bust?
02:32PM  Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
12:07PM  Biogen's Spinal Muscular Atrophy Drug Wins FDA Approval at TheStreet
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. It offers TECFIDERA, AVONEX, and PLEGRIDY to treat relapsing forms of multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn's disease; and FAMPYRA to improve walking ability for patients with MS. The company also provides ELOCTATE to treat adults and children with hemophilia A for control of bleeding episodes; ALPROLIX to treat adults and children with hemophilia B for control of bleeding episodes; RITUXAN for treating non-Hodgkin's lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), as well as two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with previously untreated CLL; and FUMADERM to treat plaque psoriasis. The company's products in Phase III development stage comprise ZINBRYTA, a monoclonal antibody for the treatment of relapsing-remitting MS; Aducanumab for Alzheimer's disease; and ISIS-SMNRx for spinal muscular atrophy. Its Phase II clinical trial products include Anti-LINGO for optic neuritis and MS; Amiselimod for multiple autoimmune indications; BAN2401 and E2609 for Alzheimer's disease; Raxatrigine for trigeminal neuralgia; rAAV-XLRS for X-linked juvenile retinoschisis; and BG00011 for idiopathic pulmonary fibrosis. Its Phase I clinical trial products comprise Dapirolizumab pegol for systemic lupus erythematosus (SLE); ISIS DMPK for myotonic dystrophy; Anti-BDCA2 for SLE; Anti-alpha-synuclein for Parkinson's disease; and BIIB063 for sjogren's syndrome. The company has a strategic research collaboration with Ionis Pharmaceuticals, Inc. It offers products primarily through its own sales force, marketing groups, and third parties worldwide. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PANGIA ROBERT WDirectorJan 09Option Exercise52.225,450284,59922,078Jan 10 04:15 PM
PANGIA ROBERT WDirectorJan 09Sale295.395,4501,609,87616,628Jan 10 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01Sale296.534814,2337,360Dec 05 04:34 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 04Sale311.9426281,7287,579Oct 05 04:24 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 03Sale313.00380118,9407,841Oct 04 05:02 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 01Option Exercise0.001,98209,154Oct 04 05:02 PM
DORSA CAROLINEDirectorSep 22Option Exercise53.6427,5701,478,85544,663Sep 26 04:24 PM
DORSA CAROLINEDirectorSep 22Sale314.0027,5708,656,98017,093Sep 26 04:24 PM
SCANGOS GEORGE AChief Executive OfficerJul 21Sale280.0015743,96054,779Jul 22 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 06Sale290.00555160,9502,402Jun 07 04:09 PM
SCANGOS GEORGE AChief Executive OfficerJun 03Sale290.00842244,18054,936Jun 06 08:14 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 02Option Exercise0.001,64303,491Jun 06 08:48 PM
SCANGOS GEORGE AChief Executive OfficerJun 01Sale287.97487140,24155,778Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 31Sale290.003,368976,72056,265Jun 02 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 25Sale280.0015743,96059,633May 27 08:59 AM
SCANGOS GEORGE AChief Executive OfficerMay 02Sale274.74487133,79859,790May 04 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Apr 06Sale275.0010228,0501,848Apr 07 05:03 PM
SCANGOS GEORGE AChief Executive OfficerApr 06Sale280.0015743,96060,277Apr 07 05:01 PM
Artavanis-Tsakonas SpyridonEVP, Chief Scientific OfficerApr 02Option Exercise0.0097503,609Apr 05 05:06 PM
SCANGOS GEORGE AChief Executive OfficerApr 01Sale258.83487126,05060,434Apr 05 05:02 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 25Sale261.9018347,9287,990Feb 26 04:08 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 23Option Exercise0.00636032,140Feb 25 05:05 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 23Option Exercise0.0057908,599Feb 25 04:59 PM
DiPietro KennethEVP Human ResourcesFeb 23Option Exercise0.0063604,237Feb 25 05:01 PM
Koppel AdamEVP, Strategy and Bus. Dev.Feb 23Option Exercise0.0030101,963Feb 25 05:02 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 23Option Exercise0.006602,709Feb 25 05:09 PM
Clancy Paul JExecutive VP and CFOFeb 23Option Exercise0.00579027,143Feb 25 05:13 PM
SCANGOS GEORGE AChief Executive OfficerFeb 23Option Exercise0.002,964062,812Feb 25 04:51 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 17Sale256.16722184,9487,990Feb 19 04:18 PM
SCANGOS GEORGE AChief Executive OfficerFeb 17Sale256.16487124,75059,848Feb 19 04:20 PM
DiPietro KennethEVP Human ResourcesFeb 12Option Exercise0.003,31604,466Feb 17 06:00 PM
Clancy Paul JExecutive VP and CFOFeb 12Option Exercise0.003,859027,768Feb 17 05:53 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12Option Exercise0.001,05702,692Feb 17 05:54 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09Option Exercise0.0011,274052,364Feb 10 04:19 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 09Sale246.54852210,0527,740Feb 10 04:17 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 08Option Exercise0.001,27809,018Feb 10 04:17 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08Option Exercise0.004,026029,666Feb 09 04:51 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08Option Exercise0.002,70907,030Feb 09 04:48 PM
DiPietro KennethEVP Human ResourcesFeb 01Option Exercise273.452,466674,3282,466Feb 02 04:05 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E23.44 EPS (ttm)6.77 Insider Own0.60% Shs Outstand955.11M Perf Week-1.97%
Market Cap151.58B Forward P/E16.69 EPS next Y9.51 Insider Trans-2.14% Shs Float934.36M Perf Month-3.20%
Income6.55B PEG1.47 EPS next Q2.07 Inst Own87.40% Short Float0.80% Perf Quarter11.12%
Sales180.90B P/S0.84 EPS this Y5.50% Inst Trans0.04% Short Ratio1.88 Perf Half Y11.92%
Book/sh39.55 P/B4.01 EPS next Y18.61% ROA5.50% Target Price181.90 Perf Year40.66%
Cash/sh13.40 P/C11.85 EPS next 5Y15.91% ROE18.30% 52W Range106.97 - 164.00 Perf YTD-0.84%
Dividend2.50 P/FCF13.95 EPS past 5Y8.00% ROI10.10% 52W High-3.57% Beta0.68
Dividend %1.58% Quick Ratio- Sales past 5Y10.80% Gross Margin- 52W Low47.85% ATR2.62
Employees200000 Current Ratio- Sales Q/Q11.60% Oper. Margin6.70% RSI (14)45.27 Volatility2.19% 1.52%
OptionableYes Debt/Eq0.88 EPS Q/Q23.00% Profit Margin3.60% Rel Volume0.87 Prev Close158.70
ShortableYes LT Debt/Eq0.69 EarningsJan 17 BMO Payout32.70% Avg Volume3.94M Price158.15
Recom1.50 SMA20-1.99% SMA500.71% SMA20011.89% Volume1,756,754 Change-0.35%
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Jun-16-16Initiated Bernstein Outperform
Jun-13-16Reiterated Mizuho Buy $156 → $156
Apr-20-16Reiterated Mizuho Buy $150 → $156
Apr-19-16Reiterated FBR Capital Outperform $130 → $145
Mar-15-16Reiterated Mizuho Buy $131 → $150
Dec-16-15Initiated Credit Suisse Outperform
Nov-20-15Reiterated Mizuho Buy $155 → $131
Nov-19-15Reiterated FBR Capital Outperform $135 → $130
Oct-02-15Initiated Citigroup Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-09-15Resumed Morgan Stanley Overweight $140
Jan-20-17 12:13PM  UnitedHealth, Aetna and Humana May Benefit From Obamacare Repeal
07:12AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bullish Manner : UNH-US : January 20, 2017
Jan-19-17 06:13PM  Why Cramer is sick and tired of investors claiming Donald Trump is unpredictable at CNBC
02:01PM  Fund manager Q&A: A broader view of sustainable investing
10:11AM  Odds of Surgery Partners' Takeout Grow
07:10AM  Target bets big on soccer with MLS, Minnesota United sponsorships at bizjournals.com
12:29AM  Financial Stocks, Dollar Rebound at The Wall Street Journal
Jan-18-17 05:25PM  US Market Indexes Mostly Higher
05:16PM  Dow logs 4-session losing streak; Nasdaq, S&P 500 end up at MarketWatch
04:41PM  Nasdaq, S&P 500 Pull Off A Win, Dow Lags; Netflix Soars On Earnings Beat
04:40PM  US STOCKS-S&P 500 ends up slightly with boost from financials
04:27PM  Dow Slides, Weighed Down by Goldman, UnitedHealth at The Wall Street Journal
12:10PM  Stock Indexes Tread Water; Will Bears Follow On Tuesday's Losses?
11:46AM  The even-bigger loss if Obamacare is repealed at MarketWatch
10:37AM  OptumRx Continues to Boost UnitedHealths Pharmacy Care Services
10:09AM  Everything You Need To Know About Aetna And Human's Pending Merger
09:55AM  ETFs in Focus on Robust Q4 UnitedHealth Earnings
09:07AM  OptumCare Expected to Become Key Growth Driver for UnitedHealth
08:15AM  Post Earnings Coverage as UnitedHealth Group Earnings Surged 56% Accesswire
07:37AM  UnitedHealths OptumHealth: Will It See Strong Revenue Growth?
12:17AM  [$$] UnitedHealths Revenue, Profit Tops Forecasts at The Wall Street Journal
Jan-17-17 06:16PM  Business Highlights
04:28PM  UnitedHealth Earnings Beat As ObamaCare Exchange Costs Improve
04:14PM  Reality of President Trump Casts Pall Over Wall Street
04:10PM  Major health insurer's growth strategy amid uncertainty over Obamacare at CNBC
04:01PM  JPMorgan, Goldman Sachs Sink DJIA on Tuesday
04:00PM  UnitedHealth looks beyond insurance to help fuel 4Q growth
02:56PM  UnitedHealth Q4 EPS Surge 56% on Strong Enrollment at Investopedia
02:35PM  Will UnitedHealths Optum One Improve Decision-Making in 2017?
01:50PM  UnitedHealth Has Trump Insurance at Bloomberg
01:47PM  Skolnick: UnitedHealth is like clockwork, can make money ...
01:05PM  Optum360: Will It Become UnitedHealths Key Growth Driver?
12:29PM  Jim Cramer: UnitedHealth Is the Managed Care Play Under Trump at TheStreet
12:06PM  [$$] UnitedHealth's Revenue, Profit Tops Forecasts at The Wall Street Journal
11:30AM  Markets Slump to Commence Inauguration Week
11:14AM  UnitedHealth Group: Robust Revenue Expected
11:12AM  UnitedHealth individual Obamacare plans recede, profit rises Reuters
10:55AM  GM, Walmart hiring plans, Morgan Stanley profit soars, British American Tobacco buys all of Reynolds American
10:52AM  Obamacare Muddle Pushes UnitedHealth Down Despite Better-Than-Expected Earnings
10:38AM  The Estimize Roundtable: Convergexs Nick Colas joins us to discuss the Trump Administration [Podcast]
10:34AM  Stocks Fall As Gold, Oil Rise; Apple, Wal-Mart Lift Dow But UnitedHealth Drags
10:20AM  Stock Market News for January 17, 2017
09:56AM  UnitedHealth (UNH) Beats on Q4 Earnings, Enrollment Grows
09:29AM  UnitedHealth CEO sees path to keep insurance for newly covered
09:21AM  UnitedHealth Finishes 2016 Strong, Has High Hopes for 2017 at Motley Fool
09:20AM  What's In Store for Dow ETF in Q4 Earnings?
09:18AM  Stock market set to open lower as Trump, Brexit rattle investors at MarketWatch
08:05AM  Globalization in focus at Davos as Theresa May talks Brexit, US readies for Trump
08:01AM  UNITEDHEALTH GROUP INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
07:48AM  Early movers: MS, UNH, WMT, TIF, TWTR, NFLX & more at CNBC
07:45AM  UnitedHealth Takes Aim at New 52-Week High After Solid Earnings
07:35AM  UnitedHealth 's (UNH) Q4 Earnings Beat, Affirms Guidance
07:12AM  5 Things You Must Know Before the Market Opens Tuesday
07:07AM  Q4 2016 UnitedHealth Group Inc Earnings Release - Before Market Open
07:04AM  Market Recon: This Is a Week of Danger, or One of Opportunity
06:30AM  Timothy P. Flynn Joins UnitedHealth Group Board of Directors Business Wire
06:12AM  UnitedHealth earnings top expectations; memberships increase at CNBC
06:04AM  Health insurer UnitedHealth's revenue rises 9 pct Reuters
05:55AM  UnitedHealth Group Reports 2016 Results Highlighted by Continued Strong and Diversified Growth Business Wire
12:21AM  [$$] UnitedHealth Is Poised to Pass Its Earnings Checkup at The Wall Street Journal
Jan-16-17 06:05PM  [$$] UnitedHealth Earnings: What to Watch at The Wall Street Journal
06:03PM  5 Reasons to Buy Magellan Health (MGLN) Stock Right Now
05:37PM  This Week's Amazing Earnings Charts
04:14PM  Trump Inauguration, Netflix, GE, IBM, Davos Forum Lead Investing Action Plan
03:51PM  What to watch in UnitedHealths earnings at CNBC
12:05PM  [$$] UnitedHealth Is Poised to Pass Its Earnings Checkup at The Wall Street Journal
10:30AM  What to Expect in UnitedHealth Q4 Earnings at Investopedia
09:23AM  What to Look for When UnitedHealth Reports Its Quarterly Results
08:35AM  Should You Buy UnitedHealth Group (UNH) Ahead of Earnings?
Jan-15-17 10:00AM  Week Ahead: Fourth-Quarter Earnings Heat Up in High-Stakes Reporting Season
Jan-13-17 07:01PM  Wall Street awaits Trump's inauguration, but two presidents could move the markets in the week ahead at CNBC
04:10PM  Here's What to Expect for UnitedHealthcare's Fourth-Quarter Earnings
02:02PM  Business events scheduled for the coming week
12:20PM  10 Stocks to Buy for Donald Trump's Second Wind at Kiplinger
12:03PM  Jim Cramer on How to Play UnitedHealth and the Obamacare Repeal at TheStreet
Jan-12-17 06:30AM  UnitedHealth: Jim Cramer's Top Takeaways
06:30AM  Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)
03:27AM  How repealing Obamacare will be Trumps Iraq at MarketWatch
Jan-11-17 07:10PM  Cramer Remix: Someone forgot to tell Trump about the Trump rally at CNBC
06:36PM  Cramer crowns the biggest healthcare winner of an Obamacare repeal at CNBC
12:00PM  CareerWise Colorado and UnitedHealthcare to Launch Apprenticeship Program in Mesa County Business Wire
08:27AM  Health Insurers Are Riding High -- Which Should You Buy?
Jan-10-17 11:22PM  UnitedHealthcare and Qualcomm Donate $50,000 to Boys & Girls Clubs of America Following 5 Million Step Challenge at CES 2017 Business Wire
02:15PM  Optum expands into KC surgery-center market with $2.3B acquisition at bizjournals.com
12:44PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Surgical Care Affiliates, Inc. to UnitedHealth Group Inc. for $57 Per Share is Fair to Shareholders -- SCAI PR Newswire
10:27AM  A.M. Best Comments on Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries Following Acquisition Announcement of Surgical Care Affiliates Business Wire
08:15AM  Blog Coverage UnitedHealth Acquires Surgical Care Affiliates for $57 per Share Accesswire
08:04AM  UnitedHealth's Unit to Expand Outpatient Surgical Procedures
06:31AM  [$$] The Dow Jones Industrial Average and 20,000 - does it matter? at Financial Times
Jan-09-17 10:22PM  Asian stocks mostly lower, tracking Wall Street losses
05:52PM  US dealmaking kicks off 2017 with biggest start in 7 years at CNBC
05:18PM  Business Highlights
04:23PM  CES: Fitbit Getting Users Active With Incentives, Games
03:12PM  UnitedHealth's Shot in the Arm at Bloomberg
12:49PM  [$$] UnitedHealth's Optum to Acquire Surgical Care Affiliates for $2.3 Billion at The Wall Street Journal
12:23PM  Why Surgical Care Affiliates Inc Operated Higher Today at Motley Fool
10:38AM  UnitedHealth buying Surgical Care for $2.3 billion
10:12AM  McDonald's sells most of its China business; Fiat Chrysler invests big in US; VCA shares are howling on Mars deal
09:57AM  The smart money looks fearless as the Dow aims for 20,000 again at MarketWatch
09:15AM  Select Medical Holdings (SEM) Provides Guidance for 2017
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, advisory consulting services, and business process outsourcing and support services to hospitals, physicians, commercial health plans, government agencies, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail pharmacy network management, home delivery and specialty pharmacy, manufacturer rebate contracting and administration, benefit plan design and consultation, claims processing, and clinical program services, such as formulary management and compliance, drug utilization review, and disease and drug therapy management. The company was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURKE RICHARD TDirectorDec 29Option Exercise52.575,000262,8501,930,030Jan 03 04:34 PM
Bueno Edson de GodoyDirectorDec 21Option Exercise55.0357,2003,147,716207,817Dec 22 08:55 PM
BURKE RICHARD TDirectorDec 15Sale159.8015,0002,397,0001,925,030Dec 15 04:36 PM
BURKE RICHARD TDirectorDec 08Sale158.6645,0007,139,4891,944,949Dec 09 04:09 PM
ROOS THOMAS EChief Accounting OfficerDec 06Sale157.602,000315,20321,083Dec 08 04:24 PM
WILENSKY GAIL RDirectorNov 17Option Exercise52.545,460286,86760,512Nov 21 04:10 PM
WILENSKY GAIL RDirectorNov 17Sale150.555,460822,00055,052Nov 21 04:10 PM
BALLARD WILLIAM C JRDirectorNov 14Sale151.213,000453,61570,039Nov 16 04:22 PM
WILSON D ELLENEVP Human CapitalOct 21Option Exercise46.1816,275751,58066,635Oct 25 05:07 PM
Shine Kenneth IrwinDirectorOct 21Sale144.9932547,12128,613Oct 25 05:08 PM
WILSON D ELLENEVP Human CapitalOct 21Sale144.1814,3652,071,10552,270Oct 25 05:07 PM
BURKE RICHARD TDirectorSep 14Option Exercise49.325,990295,4421,989,540Sep 15 05:13 PM
BURKE RICHARD TDirectorSep 07Sale135.3140,0005,412,2161,983,550Sep 09 04:52 PM
BALLARD WILLIAM C JRDirectorAug 25Option Exercise52.575,000262,85072,630Aug 29 04:32 PM
BALLARD WILLIAM C JRDirectorJun 16Option Exercise49.435,000247,15072,229Jun 20 04:27 PM
BURKE RICHARD TDirectorJun 16Option Exercise45.415,840265,2192,023,149Jun 20 04:28 PM
BALLARD WILLIAM C JRDirectorJun 16Sale138.585,000692,89567,229Jun 20 04:27 PM
BURKE RICHARD TDirectorMay 13Sale129.3025,0003,232,5332,017,309May 17 04:34 PM
Shine Kenneth IrwinDirectorApr 20Option Exercise25.1662515,72528,680Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Option Exercise45.015,000225,05073,229Apr 22 04:18 PM
BALLARD WILLIAM C JRDirectorApr 20Sale134.875,000674,35568,229Apr 22 04:18 PM
Shine Kenneth IrwinDirectorApr 20Sale132.29962127,26628,055Apr 22 04:18 PM
BURKE RICHARD TDirectorMar 29Option Exercise54.689,290508,0022,041,972Mar 30 04:49 PM
WILENSKY GAIL RDirectorMar 14Option Exercise45.235,420245,13459,025Mar 15 04:59 PM
WILENSKY GAIL RDirectorMar 14Sale124.515,420674,82053,605Mar 15 04:59 PM
WILSON D ELLENEVP Human CapitalMar 07Sale121.514,113499,75349,903Mar 08 04:27 PM
WICHMANN DAVID SPresident & CFOMar 02Option Exercise48.58150,0007,287,000746,536Mar 04 04:29 PM
WILENSKY GAIL RDirectorFeb 16Option Exercise55.128,530470,15462,135Feb 17 05:15 PM
WILENSKY GAIL RDirectorFeb 16Sale114.008,530972,42053,605Feb 17 05:15 PM
BURKE RICHARD TDirectorFeb 04Sale113.6950,0005,684,6102,032,605Feb 05 04:36 PM
BALLARD WILLIAM C JRDirectorFeb 01Option Exercise55.478,000443,76075,815Feb 03 04:46 PM
BALLARD WILLIAM C JRDirectorFeb 01Sale114.938,000919,44467,815Feb 03 04:46 PM
HEMSLEY STEPHEN JChief Exec OfficerJan 29Option Exercise59.42200,00011,884,0003,263,825Jan 29 07:20 PM
HEMSLEY STEPHEN JChief Exec OfficerJan 29Sale113.30200,00022,660,7003,063,875Jan 29 07:20 PM
BURKE RICHARD TDirectorJan 22Option Exercise59.4276045,1592,082,605Jan 26 04:49 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E22.57 EPS (ttm)1.23 Insider Own0.10% Shs Outstand2.10B Perf Week1.24%
Market Cap58.05B Forward P/E19.46 EPS next Y1.42 Insider Trans0.19% Shs Float1.41B Perf Month6.51%
Income2.53B PEG3.98 EPS next Q0.33 Inst Own36.20% Short Float1.56% Perf Quarter2.37%
Sales22.70B P/S2.56 EPS this Y-14.40% Inst Trans0.22% Short Ratio4.16 Perf Half Y-6.33%
Book/sh10.40 P/B2.66 EPS next Y16.46% ROA5.00% Target Price32.04 Perf Year38.21%
Cash/sh0.03 P/C1016.69 EPS next 5Y5.67% ROE11.90% 52W Range19.00 - 30.10 Perf YTD2.33%
Dividend1.64 P/FCF- EPS past 5Y16.90% ROI8.30% 52W High-7.79% Beta0.91
Dividend %5.93% Quick Ratio0.50 Sales past 5Y-4.30% Gross Margin15.10% 52W Low46.07% ATR0.46
Employees6800 Current Ratio0.80 Sales Q/Q-6.10% Oper. Margin15.80% RSI (14)66.24 Volatility1.24% 1.58%
OptionableYes Debt/Eq1.10 EPS Q/Q-6.80% Profit Margin11.10% Rel Volume0.67 Prev Close27.67
ShortableYes LT Debt/Eq0.97 EarningsJan 30 BMO Payout129.20% Avg Volume5.31M Price27.75
Recom1.60 SMA202.17% SMA506.05% SMA2003.10% Volume1,813,437 Change0.30%
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Jan-20-17 09:30AM  The Zacks Analyst Blog Highlights: Hess, RPC, Chevron, Anadarko Petroleum and Enterprise Products Partners
Jan-19-17 09:45AM  Plains All American to boost capacity on Permian Basin to Corpus Christi pipeline at bizjournals.com
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
05:20PM  Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017
03:35PM  Williams Partners Got Upgrade after Financial Repositioning
Jan-17-17 10:48AM  Which Midstream Stocks Have the Highest Implied Volatility?
Jan-13-17 08:54AM  Why You Should (and Shouldn't) Buy Enterprise Products Partners L.P. at Motley Fool
Jan-10-17 03:38PM  Williams Announces Major Financial Repositioning
10:37AM  What Are Analysts Recommending for Enbridge?
10:19AM  Rice Midstream Sees a Sudden Rise in Implied Volatility
Jan-09-17 01:17PM  Will Kinder Morgan Report Higher 4Q16 Earnings?
12:21PM  Is Enterprise Products Setting Up for a Breakout? at Investopedia
10:38AM  DCP Midstream Partners to Become US Largest NGLs Producer
10:37AM  Which MLPs Look Attractive for 2017?
09:06AM  How Does TC PipeLines Valuation Compare to Its Peers?
08:55AM  Enterprise Products Partners to Participate in UBS MLP One-on-One Conference Business Wire
07:36AM  Why Institutional Investors Seem Bullish on MLPs in 2017
Jan-08-17 09:25AM  3 Oil Stocks to Buy in January at Motley Fool
08:11AM  Top Oil Stocks to Buy in 2017 at Motley Fool
08:04AM  Top Gas Stocks to Buy in 2017 at Motley Fool
Jan-06-17 02:35PM  High Leverage Remained a Concern for MLPs in 2016
10:55AM  7 Dividend Stocks to Put on Your Shopping List at Motley Fool
09:09AM  Enterprise Products (EPD) Hikes Quarterly Distribution
07:45AM  7 MLP Giants That Keep Raising Distributions, Even Through Recent Hard Times
Jan-05-17 04:30PM  DryShips Inc.'s Stock Got Absolutely Pulverized in 2016, But the Worst May Be Over at Motley Fool
08:54AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jan-04-17 02:36PM  Kelley: Still deals to be made in oil sector
11:42AM  Why High Implied Volatility Midstream Stocks Move More Sharply
06:31AM  Tax repatriation favors mid-cap stocks: Pro
Jan-03-17 10:05AM  Stifel Select List Energy MLPs to Buy for 2017
Dec-30-16 10:35AM  How Does Shell Midstream Partnerss Valuation Compare with Its Peers?
07:38AM  Could ETE Further Simplify Its Organizational Structure in 2017?
Dec-28-16 07:35AM  How Many Analysts Are Rating Enterprise Products Partners a Buy?
Dec-27-16 02:43PM  Summit Midstream Partners Is RBC Capitals Top Pick for 2017
12:06PM  Bullish and Bearish Reversals in the Market
10:36AM  What Do the Valuations of EPD, PAA, WPZ, and MMP Indicate?
09:06AM  A Key Metric Comparison of Four Master Limited Partnerships
07:35AM  Whats Happening with Short Interest in Plains All American Pipeline?
Dec-26-16 10:36AM  Which Master Limited Partnerships Are Institutional Investors Buying?
09:06AM  Magellan Midstream Continues to Invest in Capital Projects
07:37AM  Which MLP Giant Has the Highest Leverage?
Dec-24-16 08:58PM  This Oil MLP Will Stuff Your Stocking With a 6% Yield
Dec-23-16 04:35PM  How EPD, MMP Offered Stable Distribution Growth in Tough Times
03:05PM  Inside the Distributable Cash Flow Growth of Four MLP Giants
01:08PM  Why Plains All American Pipeline Outperformed Peers in 2016
Dec-22-16 07:36AM  How US Ethane Exports Could Pick Up alongside Natural Gas Exports
01:00AM  U.S. refiners cash in on Mexico's record fuel imports Reuters
Dec-21-16 10:18AM  Analyzing Midstream Stocks Returns and Implied Volatility
07:36AM  Forget Kinder Morgan, Inc.: Here Are 3 Better Dividend Stocks at Motley Fool
Dec-20-16 10:35AM  Enterprise Products Partners: Is the Worst Over?
10:07AM  2 Dividend Stocks to Stay Away From -- and 1 Worth Buying at Motley Fool
09:05AM  What Short Interest in Enterprise Products Partners Stock Means
07:35AM  Are Institutional Investors Selling Their EPD Holdings?
Dec-19-16 12:20PM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : October 31st, 2016 (record date) : By the numbers : December 19, 2016
10:35AM  Enterprise Products Partners Valuation: What Does It Mean?
09:05AM  Likely Additions to Oil Supply: Tailwind for Enterprise Products?
07:35AM  Why Enterprise Products Partners Leverage Isnt a Concern
Dec-16-16 03:52PM  8 MLP Picks for 2017 from RBC at Barrons.com
10:36AM  What Will Drive Enterprise Products Partners Growth?
09:06AM  Enterprise Products Partners: Taking the Organic Growth Route
07:36AM  Enterprise Products Partners: A Key Player in US LPG Exports
06:04AM  These 5 Big Stocks Could Be Turning 'Toxic'
Dec-15-16 05:05PM  Forget Vanguard Natural Resources, LLC: These 3 Stocks Are Better Buys at Motley Fool
03:35PM  Enterprise Products Gas Gathering, Processing: Contributing Less
02:05PM  Which Segment Drives Enterprise Products Partners Performance?
12:28PM  Whats Ahead for Enterprise Products Partners Stock in 2017?
11:40AM  Enterprise Products Partners LP Value Analysis (NYSE:EPD) : December 15, 2016
10:30AM  Enterprise Resumes Service at Pascagoula Natural Gas Processing Plant Business Wire
Dec-14-16 07:32AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : December 14, 2016
Dec-13-16 08:15AM  How Do Midstream Stocks Returns Affect Implied Volatility?
Dec-12-16 10:50PM  No Breakout for Enterprise Products on OPEC News at Investopedia
Dec-11-16 11:49AM  3 Safe Stocks You Can Buy Right Now at Motley Fool
Dec-09-16 04:35PM  KYN and TYG: MLP Investing through Mutual Funds
04:05PM  Whats Driving Williams Companies Recent Operating Performance?
03:05PM  Analyzing Top MLP Stocks Long-Term Performance
01:19PM  EPD, WPZ, and PAA: How Top MLPs Performed in 2016
Dec-08-16 08:55PM  Is Enterprise Products Partners Ready to Drop? at Investopedia
Dec-07-16 08:05AM  The Word on the Street: What Analysts Are Saying about Kinder Morgan
Dec-06-16 02:52PM  Enterprise Products Bouncing Up and Down (EPD) at Investopedia
12:26PM  Which Volatile Midstream Stocks Have Been Moving Lately?
Dec-05-16 09:21AM  4 winning investment moves for the Trump tax era at CNBC
08:55AM  Enterprise Products Partners to Present at Wells Fargo Pipeline, MLP and Utility Symposium Business Wire
Dec-04-16 05:06PM  The Secret Behind Enterprise's Falling Price (EPD) at Investopedia
05:37AM  5 Dividend Stocks to Buy in December at Motley Fool
Dec-02-16 03:04PM  Analyzing the Recent Trends in MLP Equity Issuance
02:40PM  Enterprise Did Not Respond Well to OPEC News (EPD) at Investopedia
Dec-01-16 05:51PM  More and More Hedge Funds Love Enterprise Products Partners L.P. (EPD) at Insider Monkey
Nov-30-16 10:17AM  Which Energy Company Is the Best Dividend Stock? at Motley Fool
08:04AM  What Does the MLP Funds Market Look Like?
Nov-28-16 10:50AM  3 High-Yield Dividend Stocks for Retirement at Kiplinger
Nov-26-16 06:03PM  Enterprise Dips Despite Strong Fundamentals (EPD) at Investopedia
08:45AM  Oil Rig Count Rises by 3; OPEC Supply Cut Talks Flounder
Nov-25-16 12:59PM  First Trust MLP and Energy Income Fund Announces Monthly Dividend
Nov-24-16 02:58PM  Enterprise Products Partners L.P. (EPD): How Safe Is This High-Yield MLPs Distribution? at Insider Monkey
Nov-23-16 10:30AM  How Do Midstream Stocks with Higher Implied Volatility Move?
08:19AM  EPD: A Good Company with Dangerous Stock Chart (EPD) at Investopedia
Nov-22-16 04:04PM  Why ETP Decided to Merge into Sunoco Logistics Partners
09:09AM  Analyzing US Crude Oil Movement by Rail in August
08:04AM  Capital Projects Should Continue to Drive ONEOKs Growth in 2017
Nov-19-16 08:10PM  Weekly Top Insider Buys Highlight for Week of Nov. 18
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
BARTH CARIN MARCYDirectorFeb 12Buy20.525,000102,6005,000Feb 17 04:06 PM
MCMAHEN CHARLES EDirectorFeb 12Buy19.9910,000199,90097,554Feb 12 04:13 PM
Montgomery William CDirectorFeb 11Buy19.6910,000196,90036,500Feb 11 06:48 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-4.94 Insider Own0.10% Shs Outstand375.25M Perf Week-0.77%
Market Cap80.52B Forward P/E13.42 EPS next Y15.98 Insider Trans1.67% Shs Float374.51M Perf Month11.29%
Income-1948.30M PEG- EPS next Q3.73 Inst Own88.40% Short Float6.05% Perf Quarter-5.86%
Sales14.90B P/S5.40 EPS this Y23.00% Inst Trans-0.07% Short Ratio4.41 Perf Half Y-13.11%
Book/sh215.93 P/B0.99 EPS next Y19.42% ROA10.30% Target Price260.11 Perf Year-26.75%
Cash/sh73.00 P/C2.94 EPS next 5Y12.26% ROE18.70% 52W Range184.50 - 301.98 Perf YTD2.18%
Dividend2.80 P/FCF34.01 EPS past 5Y-50.40% ROI-1.30% 52W High-28.81% Beta1.07
Dividend %1.30% Quick Ratio3.90 Sales past 5Y33.40% Gross Margin83.30% 52W Low16.52% ATR5.06
Employees31200 Current Ratio4.00 Sales Q/Q4.40% Oper. Margin-9.80% RSI (14)62.45 Volatility2.20% 2.35%
OptionableYes Debt/Eq0.39 EPS Q/Q52.20% Profit Margin94.40% Rel Volume0.58 Prev Close214.58
ShortableYes LT Debt/Eq0.37 EarningsFeb 08 BMO Payout0.00% Avg Volume5.13M Price214.98
Recom2.00 SMA202.18% SMA506.90% SMA200-5.03% Volume1,513,746 Change0.19%
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Jan-20-17 11:53AM  Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon
10:37AM  Synergy Pharmaceuticals Secures Approval for Linzess Competitor
08:17AM  Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan-19-17 09:35AM  Bull-Bear Battle Coming to a Head for Allergan at Investopedia
09:30AM  Should Value Investors Choose Allergan (AGN)?
09:04AM  Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
08:07AM  Allergan says the FDA has approved its cream for facial redness at MarketWatch
07:59AM  Allergan Announces FDA Approval Of RHOFADE (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults PR Newswire
Jan-18-17 04:27PM  Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids at The Wall Street Journal
04:22PM  Allergan's Uterine Fibroids Candidate Positive in Phase III
07:25AM  Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions
12:30AM  PRESS DIGEST- Wall Street Journal - Jan 18 Reuters
Jan-17-17 05:49PM  [$$] Allergan Admits to Disclosure Violations During Valeant Bid at The Wall Street Journal
10:33AM  AGN Falls Despite Positive Trial Results at Investopedia
02:01AM  Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids PR Newswire
Jan-16-17 01:00AM  Allergan, Schlumberger, IBM: Doug Kass' Views
Jan-14-17 05:59AM  Jobless Claims and Trimming GLD: Best of Kass
Jan-12-17 02:45PM  Pharma company executives debate drug pricing increases
02:00PM  Lawsuit accuses Shire of monopolizing market for ADHD drug at bizjournals.com
08:00AM  Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast PR Newswire
Jan-11-17 07:01PM  Cramer: Trump Doesn't Seem to Care About the Trump Rally
04:16PM  Correction: Drug Prices-Johnson & Johnson story
02:22PM  Mylan CEO Heather Bresch says keeping drug price hikes below 10% isnt the answer at MarketWatch
01:26PM  Trump's Comments Are Big Pharma's Nightmare at Forbes
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:26PM  Trump's Comments Are Big Pharma's Nightmare
08:36AM  Allergan Shifts Strategy to Focus on Growth at TheStreet
Jan-10-17 08:01PM  Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
04:51PM  Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
04:06PM  5 Manufacturing Stocks With 25% Upside Potential
12:59PM  Todd Hagopian's Top Biotech Takeover Targets For 2017 at Forbes
12:45PM  Allergan CEO: Seeing constructive movement by entire indu...
09:09AM  Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes at Motley Fool
Jan-09-17 03:47PM  AGN Makes Two Small Deals at Investopedia
03:05PM  Allergan wants to buy a Cambridge biotech founded by ex-Genzyme CEO at bizjournals.com
11:21AM  Teva Pharmaceutical Industries Ltd -- Moody's: Operating Headwinds Weigh On Teva's 2017 Deleveraging Plans -- A Credit Negative at Moody's
11:13AM  [video]Allergan Continues Down 'Stepping Stone' Path With Two Deals
08:30AM  Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs GlobeNewswire
07:39AM  Teva Falls on Disappointing 2017 Sales & Earnings Guidance
01:00AM  Allergan, Google, Oaktree Capital: Doug Kass' Views
Jan-07-17 03:03PM  These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
Jan-06-17 09:00PM  Craft a Strategy From Retail's Wreckage: Best of Kass
08:09PM  Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
04:22PM  ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers
03:26PM  Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway? at Barrons.com
01:26PM  Allergan CEO on the Hot Seat: Here's What He Had to Say at Motley Fool
07:24AM  Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View
Jan-05-17 04:01PM  Allergan Pops On 2017 Guidance; Can It Survive Alzheimer's Rivalries?
03:38PM  Allergan: No More "Aspirational" Financial Guidance at Barrons.com
12:52PM  Cooperman's best ideas: 14 stock picks
11:19AM  Allergan Is Playing Its Cards Close To The Vest at Investopedia
10:07AM  Saunders Paints Realistic Outlook for Allergan in 2017
08:57AM  Allergan issues 2017 guidance, expects double-digit EPS growth at MarketWatch
08:29AM  How Trump-related uncertainty is bringing out the health-care stock bears at MarketWatch
08:16AM  Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
07:52AM  Allergan expects mid-single digit 2017 revenue growth
07:30AM  Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook PR Newswire
06:45AM  What Pharma and Healthcare Investors Should Watch For at JPM Next Week
Jan-04-17 11:14AM  Allergan Plc (AGN) Explodes After FDA Approval Of Natrelle Inspira at Insider Monkey
08:33AM  Allergan Natrelle Inspira Breast Implants Approved in the U.S.
07:35AM  FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg PR Newswire
Jan-03-17 07:20PM  Abraham, Fruchter & Twersky, LLP Files Securities Class Action Lawsuit Against Allergan PLC (NYSE: AGN) Marketwired
04:15PM  Allergan to Present at 35th Annual J.P. Morgan Healthcare Conference PR Newswire
02:42PM  New year, new drug prices
12:32PM  Allergan Drug Price Hikes Are in Effect, Though Increases Are Modest at TheStreet
11:01AM  Allergan Continues 2017 Where It Left Off In 2016 at Investopedia
10:31AM  EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN PR Newswire
09:48AM  Allergan took its pricing pledge last fall about as literally as it gets at MarketWatch
07:35AM  Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants PR Newswire
Jan-02-17 10:25AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses In Excess of $100,000 of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
01:00AM  Starbucks, Allergan, Amazon: Doug Kass' Views
Dec-30-16 01:15PM  Apollo Endosurgery Shares Up 20% After Going Public With Reverse Merger
11:15AM  3 Sleeper Biotechs That Could Bounce Back Strong in 2017
10:30AM  GPM Reminds Investors of the January 3 Deadline in the Class Action Lawsuit Against Allergan PLC Business Wire
08:58AM  Apple and Microsoft: Moving Opposite on Share Buybacks?
08:00AM  Brent Saunders's New Model Will Be Tested in 2017 at Bloomberg
07:35AM  Analyzing Mercks General Medicine and Womens Health Segment
Dec-29-16 04:19PM  Bulls Are Pushing Allergan Shares Higher at Investopedia
10:10AM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) & Lead Plaintiff Deadline: January 3, 2017 GlobeNewswire
07:00AM  Healthcare: What Does a Trump Administration Mean for Healthcare Stocks? at Morningstar
Dec-28-16 03:42PM  January 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Allergan PLC Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
03:05PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The January 3, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Allergan plc To Contact The Firm - AGN GlobeNewswire
09:06AM  VRXs Gastrointestinal Segment Saw Robust Revenue Growth in 2016
06:52AM  Biotech plays for the new year
Dec-27-16 02:13PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline Accesswire
11:53AM  Shares of Allergan Showing Positive Momentum at Investopedia
11:00AM  Biotech Poised for Rebound
10:02AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
Dec-26-16 09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
Dec-25-16 10:05PM  Asian stocks lower in light trading after Christmas
Dec-23-16 07:01PM  Cramer: Count Your Blessings, It's OK to Like Stocks Again
04:48PM  ALLERGAN ALERT: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action Filed by Firm - AGN GlobeNewswire
04:37PM  US stocks inch higher in slow pre-holiday trading
04:04PM  Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
02:52PM  Allergan Is Gaining Traction -- Plus Jim Cramer's Take
09:30AM  The Zacks Analyst Blog Highlights: FedEx, Verizon, Morgan Stanley, Caterpillar and Allergan
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
05:48AM  Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E21.20 EPS (ttm)5.40 Insider Own0.10% Shs Outstand292.70M Perf Week3.50%
Market Cap33.49B Forward P/E18.67 EPS next Y6.13 Insider Trans-19.51% Shs Float290.51M Perf Month7.27%
Income1.61B PEG1.94 EPS next Q1.36 Inst Own69.40% Short Float1.16% Perf Quarter21.25%
Sales9.92B P/S3.38 EPS this Y-20.10% Inst Trans-0.07% Short Ratio1.71 Perf Half Y26.36%
Book/sh42.35 P/B2.70 EPS next Y9.76% ROA4.70% Target Price107.50 Perf Year65.43%
Cash/sh3.36 P/C34.04 EPS next 5Y10.92% ROE13.10% 52W Range63.24 - 116.00 Perf YTD5.88%
Dividend2.36 P/FCF83.94 EPS past 5Y4.90% ROI8.90% 52W High-3.34% Beta1.23
Dividend %2.06% Quick Ratio0.90 Sales past 5Y2.00% Gross Margin42.70% 52W Low77.28% ATR2.52
Employees30456 Current Ratio1.00 Sales Q/Q-7.00% Oper. Margin29.80% RSI (14)57.91 Volatility2.56% 1.93%
OptionableYes Debt/Eq0.82 EPS Q/Q4.10% Profit Margin16.20% Rel Volume1.13 Prev Close114.42
ShortableYes LT Debt/Eq0.77 EarningsJan 25 BMO Payout43.40% Avg Volume1.97M Price112.12
Recom2.70 SMA202.22% SMA504.99% SMA20020.80% Volume1,134,287 Change-2.01%
Jan-18-17Initiated Buckingham Research Neutral
Jan-10-17Downgrade CLSA Outperform → Underperform
Jan-09-17Downgrade Seaport Global Securities Buy → Neutral $101 → $106
Nov-02-16Upgrade Argus Hold → Buy
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-11-16Upgrade BofA/Merrill Neutral → Buy
Jun-03-16Resumed Morgan Stanley Underweight
May-19-16Initiated Credit Agricole Outperform
Apr-25-16Resumed JP Morgan Neutral
Apr-22-16Upgrade UBS Neutral → Buy $84 → $102
Apr-22-16Upgrade Credit Suisse Neutral → Outperform
Apr-22-16Reiterated Cowen Outperform $89 → $101
Apr-22-16Reiterated Barclays Equal Weight $88 → $90
Apr-13-16Resumed BofA/Merrill Neutral
Jan-28-16Upgrade Avondale Mkt Underperform → Mkt Perform
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $84 → $74
Jan-28-16Reiterated Cowen Outperform $93 → $89
Jan-28-16Downgrade Buckingham Research Buy → Neutral
Dec-07-15Upgrade Barclays Underweight → Equal Weight $76 → $95
Nov-02-15Downgrade Macquarie Neutral → Underperform
Jan-20-17 07:38AM  Why CSXs Merchandise Revenue Rose in 4Q16
12:19AM  [$$] CSX Investors Cheered by Former Rail Rivals Sudden Switch at The Wall Street Journal
Jan-19-17 07:32PM  [$$] Railroad Maverick Buoys CSX Investors at The Wall Street Journal
04:53PM  The Hot Stock: CSX Surges 23% at Barrons.com
04:14PM  CSX shares explode on activist expectations
04:12PM  CSX Jumps As Outgoing Canadian Pacific CEO Reportedly Eyes Shakeup
03:21PM  Former CP CEO teaming with investor to target CSX railroad
02:42PM  [$$] CSX shares soar as rail industry veteran takes aim at Financial Times
11:07AM  All Aboard the CSX Activist Train at Bloomberg
09:42AM  CSX Surges as Activists Said to Target Railroad for Overhaul at Bloomberg
09:11AM  Canadian Pacific CEO Exit: 'Never A Dull Moment In Calgary'
07:15AM  Canadian Pacific (CP) Down on Q4 Earnings & Revenue Miss
Jan-18-17 09:42PM  Railroad Vet Teams With Activist to Target CSX
07:49PM  Canadian Pacific CEO's Early Exit Sends CSX Shares Soaring
10:06AM  Norfolk Southern (NSC) Q4 Earnings: What Lies in Store?
08:20AM  CSX Corporation (CSX) Beats on Q4 Earnings and Revenues
07:37AM  These Huge Declines Pulled Down CSXs Carloads in the First Week of 2017
06:50AM  Coverage initiated on Norfolk Southern by Buckingham Research
Jan-17-17 05:35PM  Why Norfolk Southerns Intermodal Volumes Slumped in the First Week of 2017
05:09PM  Transports off the rails?
04:05PM  How Do Norfolk Southerns Carloads Compare to Other US Railroads?
01:01PM  Why Railroad Stocks Won't Run You Over This Earnings Season
Jan-16-17 07:37AM  Why Most Analysts Still Rate Union Pacific a Buy
Jan-12-17 07:37AM  How Do Analysts View CSX Corporation ahead of Its 4Q16 Results?
Jan-10-17 10:36AM  Double-Digit Rise in Volumes Minus Coal Pushed CNIs Carloads Up
Jan-09-17 10:38AM  Norfolk Southerns Intermodal Volumes Continue Their Momentum
09:07AM  Fall in Volumes Minus Coal Pulled Down Norfolk Southerns Carloads
Jan-06-17 04:31PM  Dow 20K: What to buy?
Jan-04-17 05:48PM  Gartman's 4 'simple' buys for 2017
09:30AM  Zacks Industry Outlook Highlights: Union Pacific, Canadian Pacific, Canadian National Railway, Kansas City Southern and Norfolk Southern
09:30AM  Zacks Industry Outlook Highlights: Kansas City Southern, Norfolk Southern, Canadian National Railways, Union Pacific and CSX
Jan-03-17 04:13PM  Merrill Lynchs Top 8 Stock Picks for the First Quarter of 2017
04:05PM  Norfolk Southern to hold fourth-quarter 2016 earnings conference call Jan. 25 PR Newswire
11:19AM  A New Infrastructure ETF For The New Year
11:16AM  Norfolk Southern Corp. : NSC-US: Dividend Analysis : November 04th, 2016 (record date) : By the numbers : January 3, 2017
Jan-02-17 07:37AM  How Does Norfolk Southerns Intermodal Volumes Compare with Industry?
Dec-30-16 06:05PM  Positive Coal Volumes Put Norfolk Southerns Carloads on Track
09:30AM  Zacks Industry Outlook Highlights: Canadian National Railways, Norfolk Southern, CSX, Union Pacific and Kansas Southern
07:10AM  Market Recon: Pension Funds Are a Bigger Deal Than Expelled Diplomats
Dec-27-16 09:06AM  Fall in Coal Volumes Pulls down Canadian Nationals Carloads
Dec-26-16 01:30PM  5 Trade Ideas for Tuesday: Ashland, Biogen, Crown Castle, Monster and Norfolk Southern
09:07AM  Strong Rise in Coal Volumes Failed to Push up CSXs Carloads
07:37AM  Norfolk Southerns Intermodal: Will Trailer Volumes Rise?
Dec-23-16 05:35PM  Which Commodity Groups Pulled Down Norfolk Southerns Carloads?
04:02PM  Intermodal Shines in US Freight Rail Volumes, Railcars Down
Dec-20-16 02:50PM  Pan Am Southern and Pan Am Railways take action to protect services over tracks used with Massachusetts Bay Transit Authority PR Newswire
01:35PM  November Winners: Wide Moat Rated Banks and Railroad Stocks
11:41AM  Why Moat Indices Outperformed Benchmarks in November
07:36AM  Norfolk Southerns Intermodal: Why Trailer Volumes Rose
Dec-19-16 06:05PM  Norfolk Southerns Carloads Compared to the Industry
04:16PM  US Freight Rail Volumes Were Mixed Bag, Canadian Railroads Surged
Dec-16-16 07:36AM  What Are FedExs Expectations for Fiscal 2017?
Dec-12-16 11:07AM  Is Norfolk Southerns Intermodal Traffic on the Path to Revival?
09:37AM  Comparing Norfolk Southerns Carloads with Industry Volumes
08:07AM  Will US Freight Rail Traffic Continue Its Upward Momentum?
Dec-10-16 12:01AM  [$$] Islamic Principles Yield Strong Results for Amana at Barrons.com
Dec-07-16 05:22PM  Dow transports set closing record high after 2-year wait
04:27PM  Broughton: Cautious about rails due to the strong dollar
12:18PM  Norfolk Southern Derailment Destroys "Cars" (NSC) at Investopedia
07:08AM  Bear of the Day: American Railcar (ARII)
Dec-06-16 10:21AM  Norfolk Southern Corporation -- Moody's affirms Norfolk Southern's Baa1 senior unsecured rating; outlook stable at Moody's
Dec-05-16 09:16AM  Five Railroad Stocks to Buy Now at Insider Monkey
Dec-01-16 08:02AM  CSX Corp Renders Bullish Update on Coal Volumes; Stock Up
Nov-30-16 02:04PM  Norfolk Southern named a Military Friendly® Employer for supporting veterans PR Newswire
Nov-29-16 02:10PM  Predicting Economic Growth By Looking at the Rails (NSC, CSX) at Investopedia
06:01AM  NORFOLK SOUTHERN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. o
Nov-28-16 05:18PM  Mitchell E. Daniels Jr. and Marcela E. Donadio elected to Norfolk Southern board PR Newswire
09:30AM  Why Moativated Investing Offers Long-Term Advantages
Nov-25-16 10:04AM  Railroads Capital Expenditure in 3Q16: Who Spent More?
08:04AM  A Quick Glance at Major US Railroads Operating Cash Flows
04:59AM  Hedge Funds Are Crazy About Norfolk Southern Corp. (NSC) at Insider Monkey
Nov-23-16 06:30AM  C.H. Robinson (CHRW) & Tesco Extend Logistics Partnership
Nov-22-16 03:35PM  Norfolk Southern's Coincidental Training Seminar (NSC) at Investopedia
03:03PM  Ship it! Transport stocks surge in what may be a good sign for market as a whole at CNBC
Nov-21-16 11:04AM  Norfolk Southerns Intermodal Traffic: Containers Up, Trailers Down
10:05AM  Comparing Norfolk Southerns Carloads with US Railroads Volumes
08:05AM  Mexican and US Freight Rail Traffic Down, Canadian Railroads Shine
Nov-18-16 03:17PM  Norfolk Southern Safety Train reaches more than 1,900 first responders on 18-city tour PR Newswire
10:04AM  Why Genesee and Wyomings European Carloads Slumped in October
08:25AM  Union Pacific (UNP) Appoints New Members to Management
08:04AM  An Insight into GWRs North American Volumes in October 2016
Nov-17-16 04:15PM  Norfolk Southern to present at Credit Suisse 4th Annual Industrials Conference on Nov. 30 PR Newswire
10:04AM  Canadian Nationals Carloads Progress despite Coals Downfall
Nov-15-16 03:21PM  Norfolk Southerns Intermodal Traffic: Why Trailers Slumped
03:21PM  How Norfolk Southerns Carloads Compare with the US Railroads
03:21PM  Freight Rail Traffic in the US, Canada, and Mexico Give Mixed Signals
Nov-14-16 05:10PM  Slidell, La., area emergency responders sharpen their skills on Norfolk Southern safety train PR Newswire
Nov-10-16 08:05AM  What Drove EXPDs Operating Margin Down in 3Q16?
Nov-09-16 03:47PM  Trump win boosts coal, hits renewable stocks Reuters
01:08PM  ETFs with exposure to Norfolk Southern Corp. : November 9, 2016
11:04AM  Why BNSFs Operating Margin Slumped in 3Q16
08:04AM  Even Coals Fall Couldnt Stop the Progression of CNIs Carloads
Nov-08-16 08:23AM  Norfolk Southern Corp. breached its 50 day moving average in a Bullish Manner : NSC-US : November 8, 2016
Nov-07-16 03:04PM  Norfolks Intermodal Traffic: Why Did Trailer Volumes Fall?
02:04PM  How Norfolk Southerns Carloads Compared to US Rail Companies
01:47PM  Railroad Stocks Lead Rally Among Transports
11:48AM  Will US Freight Rail Traffic See Light at the End of the Tunnel?
Nov-03-16 09:05AM  Transportation Stocks Q3 Earnings Coming Up: USAK, TNP
08:04AM  Why Analysts Say Hold Norfolk Southern for Now
Nov-02-16 01:51PM  Analysts Hitch Their Train To Norfolk Southern, Upgrade Stock To Buy
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods. It also transports overseas freight through various Atlantic and Gulf Coast ports; provides logistics services; and operates scheduled passenger trains. In addition, the company engages in the acquisition, leasing, and management of coal, oil, gas, and minerals; development of commercial real estate; telecommunications; and leasing or sale of rail property and equipment. As of March 1, 2016, it operated approximately 20,000 miles of road in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hurlbut Thomas EVice President and ControllerNov 18Sale103.7746948,6677,041Nov 21 03:03 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Option Exercise47.762,700128,9524,759Nov 18 03:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Sale103.171,654170,6402,622Nov 18 03:30 PM
Squires James AChairman, President and CEONov 11Option Exercise42.764,676199,93749,643Nov 14 10:41 AM
STEWART MARTA REVP-Finance and CFONov 11Sale100.901,970198,7739,774Nov 14 10:15 AM
STEWART MARTA REVP-Finance and CFONov 10Sale100.082,017201,86111,744Nov 14 10:15 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Option Exercise38.7114,417558,010136,234Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Option Exercise38.714,417170,9604,417Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Sale99.004,417437,2980Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Sale97.0014,4171,398,449121,817Nov 10 09:45 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Option Exercise38.7110,000387,050142,647Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Option Exercise50.744,530229,8524,530Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Sale96.184,530435,6730Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Sale95.4820,8301,988,850121,817Nov 10 09:45 AM
STEWART MARTA REVP-Finance and CFONov 07Sale94.102,023190,3647,824Nov 08 03:43 PM
Hurlbut Thomas EVice President and ControllerNov 07Sale94.461,00094,4617,560Nov 08 03:44 PM
Hurlbut Thomas EVice President and ControllerOct 27Sale91.212,170197,9208,560Oct 28 04:43 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsOct 03Option Exercise59.785,016299,851132,647Oct 04 04:26 PM
STEWART MARTA REVP-Finance and CFOSep 19Option Exercise75.141,33099,93612,127Sep 20 01:58 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Option Exercise38.718,557331,199136,188Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 30Sale94.158,557805,642127,631Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Option Exercise38.711,44355,851129,074Aug 31 11:43 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsAug 29Sale94.161,443135,866127,631Aug 31 11:43 AM
STEWART MARTA REVP-Finance and CFOAug 25Option Exercise62.751,59399,95310,797Aug 29 10:36 AM
Hurlbut Thomas EVice President and ControllerAug 24Sale92.2885078,43810,730Aug 25 02:30 PM
STEWART MARTA REVP-Finance and CFOAug 19Sale91.541,562142,9859,204Aug 19 03:48 PM
STEWART MARTA REVP-Finance and CFOAug 18Sale91.581,502137,55310,766Aug 19 03:48 PM
Hurlbut Thomas EVice President and ControllerAug 17Option Exercise38.711,01739,36312,597Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 17Sale89.301,01790,81811,580Aug 18 04:52 PM
Hurlbut Thomas EVice President and ControllerAug 03Sale88.3552846,64711,580Aug 04 11:59 AM
Hurlbut Thomas EVice President and ControllerMay 05Sale89.9266860,07012,203May 06 02:24 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Option Exercise49.566,500322,1086,500Apr 26 04:51 PM
Earhart Cynthia CExec. VP - Admin. and CIOApr 25Sale90.046,500585,2480Apr 26 04:51 PM
Wheeler Michael JosephEVP & Chief Operating OfficerApr 22Option Exercise57.562,436140,21411,715Apr 26 10:50 AM
STEWART MARTA REVP-Finance and CFOFeb 24Option Exercise47.762,09399,96212,471Feb 25 02:28 PM
Earhart Cynthia CExec. VP - Admin. and CIOJan 27Option Exercise0.001,00001,000Jan 29 03:46 PM
HIXON JAMES AExec. VP-Law & Corp. RelationsJan 27Option Exercise0.003,0000136,466Jan 29 03:46 PM
Hurlbut Thomas EVice President and ControllerJan 27Option Exercise0.001,000011,576Jan 29 03:46 PM
Manion Mark DExec. Vice President & COOJan 27Option Exercise0.003,000023,565Jan 29 03:46 PM
Shaw Alan H.EVP & Chief Marketing OfficerJan 27Option Exercise0.0060001,482Jan 29 03:45 PM
Squires James AChairman, President and CEOJan 27Option Exercise0.003,000037,222Jan 29 03:45 PM
Wheeler Michael JosephSr. Vice President OperationsJan 27Option Exercise0.001,00007,973Jan 29 03:45 PM
STEWART MARTA REVP-Finance and CFOJan 27Option Exercise0.001,00009,047Jan 29 03:45 PM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E17.69 EPS (ttm)6.93 Insider Own0.20% Shs Outstand351.85M Perf Week-0.06%
Market Cap43.12B Forward P/E13.96 EPS next Y8.78 Insider Trans-13.37% Shs Float349.02M Perf Month-3.15%
Income2.45B PEG1.51 EPS next Q1.44 Inst Own91.00% Short Float1.67% Perf Quarter10.21%
Sales62.48B P/S0.69 EPS this Y19.30% Inst Trans0.01% Short Ratio1.95 Perf Half Y5.65%
Book/sh52.03 P/B2.36 EPS next Y9.44% ROA3.90% Target Price140.07 Perf Year18.83%
Cash/sh54.19 P/C2.26 EPS next 5Y11.73% ROE14.20% 52W Range91.62 - 136.22 Perf YTD-0.97%
Dividend1.00 P/FCF8.44 EPS past 5Y10.20% ROI11.50% 52W High-10.18% Beta0.61
Dividend %0.82% Quick Ratio- Sales past 5Y12.00% Gross Margin- 52W Low33.55% ATR2.39
Employees50100 Current Ratio- Sales Q/Q5.50% Oper. Margin7.70% RSI (14)44.97 Volatility1.83% 1.93%
OptionableYes Debt/Eq1.13 EPS Q/Q7.20% Profit Margin3.90% Rel Volume0.74 Prev Close122.56
ShortableYes LT Debt/Eq1.10 EarningsJan 31 BMO Payout14.30% Avg Volume2.99M Price122.36
Recom2.00 SMA20-0.85% SMA50-1.96% SMA2004.45% Volume1,132,758 Change-0.16%
Jan-04-17Initiated Piper Jaffray Neutral
Nov-14-16Downgrade Bernstein Outperform → Mkt Perform
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Jun-16-16Initiated Bernstein Outperform
Apr-29-16Reiterated RBC Capital Mkts Outperform $140 → $144
Feb-02-16Reiterated Wedbush Neutral $130 → $120
Feb-02-16Reiterated RBC Capital Mkts Outperform $142 → $140
Jan-08-16Downgrade Jefferies Buy → Hold
Dec-16-15Initiated Credit Suisse Neutral
Sep-18-15Upgrade Cantor Fitzgerald Hold → Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $159 → $162
Jul-30-15Upgrade BofA/Merrill Neutral → Buy $132
Jul-06-15Downgrade FBR Capital Outperform → Mkt Perform $130
Jun-26-15Reiterated Leerink Partners Outperform $145 → $150
Jun-24-15Initiated RBC Capital Mkts Sector Perform $159
Jun-17-15Reiterated Leerink Partners Outperform $135 → $145
May-12-15Reiterated Leerink Partners Outperform $130 → $135
Apr-29-15Reiterated Argus Buy $115 → $130
Mar-12-15Reiterated Argus Buy $103 → $115
Jan-20-17 12:13PM  UnitedHealth, Aetna and Humana May Benefit From Obamacare Repeal
Jan-18-17 02:40PM  Allina, Aetna to launch Twin Cities health insurer at bizjournals.com
12:12PM  Trump health pick Price defends investments, Obamacare replacement Reuters
11:46AM  The even-bigger loss if Obamacare is repealed at MarketWatch
10:09AM  Everything You Need To Know About Aetna And Human's Pending Merger
06:14AM  3 things to watch during Tom Prices confirmation hearing at CNBC
06:00AM  Trump's health pick set to defend investments at U.S. Senate hearing Reuters
12:07AM  [$$] Women Make Gains Toward Winning CEO Job at The Wall Street Journal
Jan-17-17 06:00PM  Aetna to Announce Fourth-Quarter and Full-Year 2016 Results Business Wire
10:38AM  The Estimize Roundtable: Convergexs Nick Colas joins us to discuss the Trump Administration [Podcast]
10:29AM  [$$] Women Make Gains Toward Winning CEO Job at The Wall Street Journal
09:41AM  The Fate Of Humana Rests In The Hands Of A Federal Judge
09:02AM  UnitedHealth Earnings Beat As ObamaCare Exchange Costs Improve
Jan-12-17 04:00PM  Insulin Drug Offers Hope for MannKind
Jan-11-17 12:29PM  Companies That Have The Most To Lose If Obamacare Is Repealed
Jan-10-17 11:03AM  Fading Trump Rally Doesn't Mean Bull Market in Stocks Is Over
09:10AM  Short-term play bets on Aetna upside
08:35AM  Aetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : January 10, 2017
Jan-09-17 08:01PM  Aetna Stock Trades Ex-Dividend Tuesday at Investopedia
02:33PM  Regardless of Judge's Decision on Humana Deal, Aetna Is Pointing Upward
09:40AM  Is Aetna (AET) a Great Stock for Value Investors?
06:46AM  How repealing Obamacare will be Trumps Iraq at MarketWatch
Jan-05-17 06:18PM  5 Stocks That Have Gotten Cheaper in Market's All-Time High
09:48AM  Replacing Obamacare will take careful timing ... and the clock is ticking at CNBC
Jan-04-17 09:30AM  Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day
08:29AM  Coverage initiated on Aetna by Piper Jaffray
07:59AM  Why Health Insurers Worry About Trump's HHS Pick, Tom Price at Forbes
Jan-03-17 06:39PM  AMA To GOP: Lay Out Obamacare Replacement Details To Americans at Forbes
06:45AM  6 Powerful Personal Finance Trends For 2017 at Forbes
Jan-01-17 02:18PM  In an Ironic Twist, Obamacare Enrollment Hits an All-Time High at Motley Fool
Dec-30-16 06:12PM  Aetna Fight for Humana Awaits Judges Ruling in U.S. Case at Bloomberg
06:12PM  Aetna Fight for Humana Awaits Court Ruling in U.S. Merger Case
05:57PM  Energy companies and banks led rally on S&P 500 in 2016
09:30AM  The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna
09:21AM  3 HMO Stocks to Consider as Aetna (AET) Falls Out of Favor
08:20AM  U.S. Faces Doctor Shortage Despite Specialist Growth at Forbes
Dec-29-16 02:33PM  Why health insurers wont cover this $300,000-a-year rare disease drug at MarketWatch
Dec-28-16 09:16AM  Trump, GOP Face Huge 'Now What?' ObamaCare Moment
08:31AM  How Obamacare's Hospital Penalties Save Medicare And Lives at Forbes
Dec-27-16 01:15PM  Aetna-Humana trial wraps up; decision expected in January at bizjournals.com
11:00AM  Top 10 Personal Health Expenses From Diabetes To Pregnancy at Forbes
08:58AM  Aetna Continues to Grow Business, Merger Remains Uncertain
08:00AM  4 Trades in Aetna: Bonus Idea
Dec-23-16 12:22PM  Estimize: 5 Stocks to watch in 2017
Dec-22-16 08:45PM  Humana and Aetna have a bit more time to get their deal done at bizjournals.com
07:51PM  [$$] Trump's Health Pick Traded Medical Stocks While in House at The Wall Street Journal
07:00AM  Health Care Uncertainty in a Trump Presidency
06:49AM  AETNA INC /PA/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Dec-20-16 06:04PM  Why UnitedHealth (UNH) Stands Tall Amid All the Noise
Dec-19-16 04:23PM  WellCare Health Sees 2017 Earnings Below Views
Dec-16-16 06:44PM  President Touts Record Obamacare Enrollment As GOP Weighs Repeal at Forbes
11:05AM  The Only Way For TrumpCare To Be 'Terrific'
Dec-15-16 06:06AM  Drugmakers push profitable, but unproven, opioid solution
Dec-14-16 04:17PM  Anthem, Humana, United Push Back On Sarepta's FDA-Approved DMD Drug
12:25AM  [$$] Aetna Executives Defend Pulling Out of Some ACA Exchanges at The Wall Street Journal
Dec-13-16 11:50AM  Aetna CEO: Withdrawal from exchanges driven by business, not antitrust concerns over Humana deal at bizjournals.com
09:05AM  Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'
Dec-12-16 09:54PM  [$$] business watch at The Wall Street Journal
05:41PM  [$$] Aetna Executives Defend Pulling Out of Some ACA Exchanges at The Wall Street Journal
02:49PM  Aetna CEO Takes Stand in DOJ Suit (AET) at Investopedia
02:15PM  U.S. seeks to undercut Aetna CEO's defense in merger fight Reuters
Dec-11-16 02:18PM  Surprise! Some Large Insurers Actually Made Money on Their Obamacare Plans at Motley Fool
Dec-10-16 09:38AM  Why Trump And The GOP Must Replace ObamaCare Now, In 2 Charts
Dec-09-16 08:16PM  Aetna CEO Denies Obamacare Pullout Driven by U.S. Merger Suit at Bloomberg
08:05PM  Aetna CEO defends merger with Humana in antitrust trial Reuters
05:02PM  Walgreens May Be Close To Store Divestitures In Rite Aid Deal at Forbes
12:13AM  In Antitrust Trial, Justice Department Questions Aetna-Humana Asset Sale Plan at The Wall Street Journal
Dec-08-16 04:35PM  In Antitrust Trial, Justice Department Questions Aetna-Humana Asset Sale Plan at The Wall Street Journal
09:00AM  Aetna Foundation and the National Center for Complex Health and Social Needs Team up to Improve Community Health Business Wire
Dec-06-16 09:31AM  DOJ, Aetna Lawyers Preview Their Upcoming Duel Over Planned Sale to Molina
08:08AM  Early movers: AMZN, AZN, AZO, F, MCD, AAPL, TOL, AET & more at CNBC
07:05AM  Lawyer in Humana-Aetna case: Government arguing about 'a pretend world' at bizjournals.com
12:09AM  [$$] Aetna and Humana Defend Merger, as Antitrust Trial Begins at The Wall Street Journal
Dec-05-16 06:19PM  U.S. attorneys argue Aetna-Humana deal violates antitrust law Reuters
05:00PM  Trial Begins in DoJ Bid to Block Aetna/Humana Merger (AET, HUM) at Investopedia
04:45PM  In Case You Missed It Monday: Markets Shrug at Italy Vote, Amazon Goes AI
04:35PM  The Biggest Loser: Aetna Slumps 3% at Barrons.com
04:24PM  [$$] Aetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins at The Wall Street Journal
04:10PM  UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump
02:40PM  U.S. attorney argues Aetna-Humana deal violates antitrust law: trial Reuters
01:30PM  Read the statement: American Medical Association president opposes Aetna-Humana merger at bizjournals.com
11:20AM  U.S. attorneys argue Aetna-Humana deal violates antitrust law - Trial Reuters
09:03AM  Next Up: Aetna Defends Its $37 Billion Bid for Humana
05:00AM  Aetnas Remedy to Salvage Humana Deal Draws Fire From U.S. at Bloomberg
Dec-04-16 11:12PM  Aetna-Humana antitrust trial to hinge on Medicare market at CNBC
02:18PM  This Trump Appointment Likely Spells Imminent Doom for Obamacare at Motley Fool
09:55AM  Healthcare Lobbies Fight To Keep 20M Obamacare Customers at Forbes
Dec-02-16 02:15PM  Aetna Board of Directors Declares Quarterly Cash Dividend Business Wire
11:33AM  New Aetna Clinical Policy Bulletin Details 'Medical Necessity' Of Sarepta's Exondys 51
Dec-01-16 07:59AM  These 4 Health Insurers Could Gain on Obamacare Repeal
Nov-30-16 09:00AM  Aetna Premier Care Network Plus Helps Reduce Costs for National Employers and Members Through Simple Access to Value-Based Care Business Wire
Nov-29-16 11:17PM  Asian stocks mixed as markets await OPEC meeting results
04:15PM  Winners & losers from repealing Obamacare
12:40PM  Aetna calls Obamacare argument in Humana merger case a 'sideshow' at bizjournals.com
10:24AM  5 Companies Reach 52-Week Highs
09:40AM  Strong 2017 Guidance Sends UnitedHealth Soaring
08:50AM  ACA, Medicare at Issue in Aetna-DOJ Case (AET) at Investopedia
Nov-28-16 04:45PM  UnitedHealth Offers Bullish 2017 Guidance; Stock Rises Late
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
Nov-27-16 02:18PM  This Should Be Trump's Top Priority as President, New Survey Shows at Motley Fool
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management services, dental, behavioral health, and vision plans on an insured basis, as well as an employer-funded or administrative services contract basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company offers its products to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. has a collaboration agreement with Commonwealth Health to introduce a new health plan; and Regional Cancer Care Associates to create an oncology medical home. The company was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coye Molly JoelDirectorNov 30Sale131.171,145150,1877,517Dec 02 05:11 PM
Lynch Karen SPresidentNov 11Sale119.5545,0005,379,92651,254Nov 15 04:06 PM
Coye Molly JoelDirectorNov 09Sale116.96862100,8208,662Nov 14 05:33 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesNov 07Sale109.789,1501,004,47812,367Nov 09 04:14 PM
GARTEN JEFFREY EDirectorSep 07Sale116.517,100827,2149,398Sep 09 04:12 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 23Sale120.318,140979,32344,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Option Exercise72.2640,0002,890,40084,883Aug 24 04:32 PM
GUERTIN SHAWN MExec. Vice President, CFOAug 22Sale120.1937,1884,469,74844,883Aug 24 04:32 PM
McCarthy Margaret MEVP, Operations & TechnologyMay 10Sale114.4539,1694,483,01056,240May 12 06:06 PM
Bertolini Mark TChairman and CEOMay 03Sale114.0033,5103,820,157390,018May 04 04:20 PM
Bertolini Mark TChairman and CEOMay 02Option Exercise39.93106,5704,255,340496,588May 04 04:20 PM
LOVEMAN GARY WEVP, Consumer Health and SvcsMar 15Buy111.458,970999,7089,675Mar 17 04:34 PM
Coye Molly JoelDirectorFeb 22Sale106.281,175124,8818,104Feb 24 04:23 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E18.84 EPS (ttm)5.42 Insider Own0.10% Shs Outstand250.23M Perf Week-0.05%
Market Cap25.54B Forward P/E20.00 EPS next Y5.10 Insider Trans-19.06% Shs Float249.28M Perf Month0.69%
Income1.36B PEG2.90 EPS next Q1.55 Inst Own82.90% Short Float1.88% Perf Quarter-2.11%
Sales9.98B P/S2.56 EPS this Y16.10% Inst Trans0.08% Short Ratio3.63 Perf Half Y-7.54%
Book/sh49.31 P/B2.07 EPS next Y6.00% ROA3.10% Target Price114.07 Perf Year16.63%
Cash/sh2.07 P/C49.31 EPS next 5Y6.50% ROE10.90% 52W Range86.64 - 113.03 Perf YTD1.43%
Dividend3.02 P/FCF- EPS past 5Y13.50% ROI5.70% 52W High-9.75% Beta0.48
Dividend %2.96% Quick Ratio0.40 Sales past 5Y2.50% Gross Margin96.70% 52W Low17.74% ATR1.67
Employees17387 Current Ratio0.40 Sales Q/Q3.20% Oper. Margin16.50% RSI (14)52.33 Volatility1.43% 1.51%
OptionableYes Debt/Eq1.40 EPS Q/Q150.90% Profit Margin13.10% Rel Volume0.60 Prev Close102.08
ShortableYes LT Debt/Eq1.10 EarningsFeb 01 BMO Payout57.90% Avg Volume1.29M Price102.01
Recom2.00 SMA200.32% SMA501.75% SMA200-1.90% Volume392,747 Change-0.07%
Feb-29-16Reiterated Barclays Overweight $111 → $110
Jan-25-16Reiterated RBC Capital Mkts Outperform $119 → $116
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Feb-28-11Downgrade Barclays Capital Overweight → Equal Weight $57 → $55
Dec-10-10Initiated Oppenheimer Perform $56
Jan-17-17 09:28PM  SoCalGas Statement on California Department of Conservation's Division of Oil, Gas and Geothermal Resources Announcement of Public Meeting PR Newswire
06:46PM  California moves toward reopening Aliso Canyon gas storage field Reuters
04:18PM  California to hold public meeting on Aliso Canyon natgas facility Reuters
Jan-16-17 10:03AM  Mexico's IEnova will invest $800 mln in 2017 on 8 projects - CEO
Jan-11-17 02:42PM  SoCalGas Announces Funding for Demonstration of Mobile CNG Refueling Solution Developed by Onboard Dynamics, Inc. PR Newswire
Jan-10-17 06:03PM  SoCalGas to Use Fiber Optic Technology to Monitor Pipelines in Real Time PR Newswire
10:10AM  Houston area dominates list of best energy cos. to work for in the U.S. at bizjournals.com
Jan-03-17 04:36PM  SDG&E President, Scott D. Drury, Begins Role PR Newswire
Dec-30-16 07:37AM  SRE, EIX, and PCG: Analyzing Utilities Current Valuations
Dec-29-16 09:08AM  Whats Next for Sempra Energy Stock?
07:37AM  Analysts Expect a Handsome Upside for Sempra Energy in 2017
Dec-28-16 07:50AM  Sempra Energy breached its 50 day moving average in a Bearish Manner : SRE-US : December 28, 2016
Dec-20-16 03:29PM  SoCalGas Lifts "SoCalGas Advisory" PR Newswire
Dec-19-16 02:14PM  SDG&E Urges Customers To Be On "High Alert" For Scam Artists PR Newswire
08:29AM  Sempra Energy (SRE) Unit Buys Ventika Facility in Mexico
Dec-18-16 08:59PM  SoCalGas Issues "SoCalGas Advisory" PR Newswire
Dec-16-16 01:07PM  Sempra Energy Declares Common Dividend PR Newswire
Dec-15-16 06:24PM  Sempra Energy Unit IEnova Completes Acquisition Of Ventika Wind Generation Facilities In Mexico PR Newswire
04:43PM  SDG&E To Upgrade Infrastructure In Orange County To Improve Reliability And Public Safety PR Newswire
12:33PM  SoCalGas Completes More than 700,000 Safety Checks in First Year of Meter Inspection Program PR Newswire
Dec-14-16 06:38PM  SDG&E Transforming Vehicle Fleet PR Newswire
02:23PM  MIT Wins Peeptrade's Global Investment Challenge
11:13AM  Sempra Energy Value Analysis (NYSE:SRE) : December 14, 2016
Dec-13-16 07:26AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : December 13, 2016
Dec-08-16 08:46AM  Hedge Funds Are Selling Sempra Energy (SRE) at Insider Monkey
Dec-06-16 03:17PM  Clean Energy Milestone: 100,000th Private Solar Array Connected To SDG&E's Power Grid PR Newswire
03:09PM  In a National First, SoCalGas and University of California Irvine Successfully Test Innovative Technology that Stores Renewable Energy PR Newswire
Dec-04-16 11:57AM  Weekly Top Insider Buys Highlight for the Week of Dec. 2
Dec-01-16 04:25PM  Calif. expects to complete Aliso Canyon natgas review in early 2017 Reuters
Nov-30-16 05:41PM  SoCalGas Announces "SoCalGas Advisory" Conservation Notification Program to Reduce Risk of Natural Gas Shortages This Winter PR Newswire
02:37PM  SoCalGas Declares Preferred Dividends PR Newswire
01:39PM  Heavy Insider Selling at Invesco Ltd. (IVZ) and Las Vegas Sands Corp. (LVS), Plus Insider Buying at 3 Other Companies at Insider Monkey
Nov-29-16 07:55PM  Port Arthur LNG Files Federal Application To Construct Natural Gas Liquefaction And Export Facilities In Texas PR Newswire
Nov-23-16 09:17PM  Sempra quits talks on Odebrecht Peru pipeline, partners scramble
06:03PM  Sempra drops bid for Odebrecht pipeline in Peru, Techint in talks
04:36PM  Media Statement On Peru Pipeline PR Newswire
03:31PM  Techint says still in talks to buy Odebrecht Peru pipeline stake
Nov-19-16 11:15AM  Peru eyes new auction for natgas pipeline contract in 2017-govt
Nov-18-16 02:10PM  Peru considers rescinding Odebrecht's pipeline contract -source
01:36AM  "Team SoCalGas" Sponsors 2016 United Way HomeWalk; Largest Participant With Over 1,300 Walkers And More Than $151,000 In Contributions PR Newswire
Nov-15-16 05:10PM  SEMPRA ENERGY Files SEC form 8-K, Change in Directors or Principal Officers
Nov-14-16 03:00PM  SoCalGas Deploys Sensors to Detect Methane and Enhance Public Safety PR Newswire
02:29PM  ETFs with exposure to Sempra Energy : November 14, 2016
Nov-11-16 05:42PM  SoCalGas Takes Part in "Utilities United Against Scams Day" To Help Protect Customers Against Fraud PR Newswire
Nov-08-16 05:00PM  LA County supervisors to vote on restricting Aliso Canyon gas injection
01:04PM  SEMPRA ENERGY Financials
Nov-07-16 03:22PM  Sempra Energy's Bad News About Cameron LNG Trumped Decent Earnings Results at Motley Fool
Nov-04-16 01:05PM  ETFs with exposure to Sempra Energy : November 4, 2016
Nov-03-16 09:02PM  Mexico's IEnova increases credit line with banks to $1.17 bln Reuters
09:25AM  Sempra Energy :SRE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016
Nov-02-16 10:39PM  Edited Transcript of SRE earnings conference call or presentation 2-Nov-16 3:00pm GMT -5.24%
10:58AM  Sempra Energy (SRE) Beats on Q3 Earnings, Keeps '16 View
10:44AM  SEMPRA ENERGY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
10:38AM  [$$] Sempra Energy Profit Soars, but Revenue Misses Expectations at The Wall Street Journal
09:57AM  Sempra Energy (SRE) Beats on Q3 Earnings, Revenues Miss
08:40AM  Sempra beats 3Q profit forecasts
08:30AM  Sempra Energy Reports Increased Third-Quarter Earnings PR Newswire
07:07AM  Q3 2016 Sempra Energy Earnings Release - 08:30 am ET
Nov-01-16 09:50PM  Utility asks to resume operations a year after well blowout
06:00PM  SoCalGas Requests Regulatory Approval to Replenish Natural Gas Supply at Aliso Canyon Storage Facility PR Newswire
07:29AM  FirstEnergy (FE) Q3 Earnings: Stock to Post a Beat Again?
Oct-31-16 10:46AM  How These Utilities Stocks are Faring? -- TerraForm Power, Sempra Energy, Talen Energy, and TerraForm Global PR Newswire
08:53AM  Sempra Energy (SRE) Q3 Earnings: Stock to Beat Estimates?
08:50AM  Why Sempra Energy (SRE) Might Surprise This Earnings Season
Oct-27-16 05:12AM  Your best investment bets for 2017 are in emerging markets at MarketWatch
Oct-26-16 08:17AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : October 26, 2016
Oct-24-16 02:20PM  SoCalGas Committed to Assisting Customers with Serious Medical Conditions PR Newswire
Oct-19-16 07:30PM  Sempra Energy To Report Third-Quarter 2016 Earnings Nov. 2 PR Newswire
01:32PM  (OFFICIAL)-SoCalGas completes most well tests at Calif. Aliso Canyon natgas facility
11:37AM  SoCalGas completes well tests at Calif. Aliso Canyon natgas facility
07:00AM  SoCalGas Provides Update on Infrastructure, Technology, and Safety Enhancements at the Aliso Canyon Natural Gas Storage Facility PR Newswire
Oct-17-16 11:47PM  Sempra Energy's IEnova Unit Announces Full Exercise Of Over-Allotment Options PR Newswire
Oct-14-16 05:12PM  SEMPRA ENERGY Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:28AM  [$$] Sempra's Mexican Unit IEnova Sells Shares to Fund Expansion at The Wall Street Journal
08:36AM  Mexico's IEnova raises $1.6 billion with stock offering Reuters
03:24AM  Sempra Energy's IEnova Unit Announces Pricing Of Common Stock Follow-On Offering PR Newswire
Oct-10-16 03:15PM  SoCalGas completes more natgas well tests at Calif. Aliso Canyon
Oct-07-16 10:23AM  SEMPRA ENERGY Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Oct-06-16 12:00AM  Ienova Share Sale Looms as Sempras Mexico Expansion Moves Ahead at Bloomberg
Oct-05-16 12:00PM  SoCalGas Chairman and CEO Dennis Arriola Receives "Leadership Excellence Award" for Efforts in Supplier Diversity PR Newswire
Oct-04-16 06:36PM  SoCalGas Demonstrates Natural Gas for "Zero Net Energy" Homes in Conjunction with KB Home and BUILDER Magazine PR Newswire
02:59PM  Mexico's IEnova to offer up to $1.4 bln in primary stock offer Reuters
Oct-03-16 11:19PM  Sempras Ienova Seeks to Raise $1.27 Billion in New Share Offer
06:41PM  SoCalGas Begins $3.4 Million Valve Station Upgrade in Palmdale PR Newswire
Sep-30-16 06:01AM  SEMPRA ENERGY Files SEC form 8-K, Material Impairments
Sep-29-16 06:12PM  Sempra Energy Records Highest Score On Political Disclosure, Accountability Index PR Newswire
09:00AM  Sempra Energy's Unit IEnova Awarded Its First Two Solar Energy Projects In Mexico PR Newswire
06:53AM  Sempra Energy (SRE) Unit Buys PEMEX's 50% Interest in JV
Sep-28-16 03:29PM  Mexico's Pemex set to announce debt management deal Reuters
11:23AM  Sempra Energy : SRE-US: Dividend Analysis : September 29th, 2016 (record date) : By the numbers : September 28, 2016
Sep-27-16 07:24PM  Sempra Energy Unit IEnova Completes Acquisition Of PEMEX Stake In Joint Venture PR Newswire
Sep-22-16 03:40PM  SoCalGas Vice President Gina Orozco-Mejia Receives Latina Corporate Pillar Award PR Newswire
12:05PM  Sempra Energy Value Analysis (NYSE:SRE) : September 22, 2016
09:23AM  Sempra IEnova Gets Nod for Acquiring PEMEX's Stake in JV
Sep-21-16 06:59PM  Sempra Energy Unit IEnova Receives Approval For Acquisition Of PEMEX Stake In Joint Venture PR Newswire
08:14AM  Sempra Energy breached its 50 day moving average in a Bullish Manner : SRE-US : September 21, 2016
Sep-19-16 04:04PM  SoCalGas Commends Governor Brown and Senator Ricardo Lara for SB 1383 PR Newswire
03:46PM  6 Reasons For Sempra Energy's Above Average Growth
Sep-15-16 12:00PM  Sempra Energy Named To Dow Jones Sustainability North America Index PR Newswire
Sep-13-16 05:29PM  Sempra Energy Announces Executive Appointments PR Newswire
Sempra Energy operates as an energy services holding company worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of December 31, 2015, this segment had approximately 1.4 million electric meters and 873,000 natural gas meters. Its Southern California Gas Company segment transmits, distributes, and stores natural gas. As of December 31, 2015, this segment had approximately 5.9 million customer meters. The company's Sempra South American Utilities segment provides electricity distribution services through 13,458 miles of distribution lines, 185 miles of transmission lines, and 36 substations. Its Sempra Mexico segment owns and operates a natural gas-fired power plant and a wind generation facility in Baja California, Mexico; natural gas distribution systems; natural gas pipelines and propane systems; and liquefied natural gas regasification terminals. The company's Sempra Renewables segment develops solar electric generation facilities in Nevada, Arizona, and California, as well as develops wind electric generation facilities in Mexico. Its Sempra Natural Gas segment owns and operates a natural gas distribution utility located in Mobile and Baldwin counties in Alabama; and a natural gas distribution utility in Forrest County, Mississippi. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROWLAND G JOYCESenior VPJan 19Sale102.592,862293,6131Jan 19 02:00 PM
Martin Jeffrey WExecutive VP and CFOJan 10Sale100.954,266430,6730Jan 10 01:57 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Option Exercise61.4112,000736,92059,425Dec 13 04:42 PM
SNELL MARK APresidentDec 12Sale103.0635,0003,607,10037,914Dec 13 04:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Sale102.6912,0001,232,28047,425Dec 13 04:42 PM
ROWLAND G JOYCESenior VPDec 08Sale99.1212512,3901Dec 09 04:11 PM
BOECKMANN ALAN LDirectorNov 29Buy101.526,000609,1166,000Nov 29 06:26 PM
MIHALIK TREVOR ISVP, Controller and CAOAug 10Sale106.865,659604,7212,615Aug 10 05:02 PM
RUTLEDGE WILLIAM PDirectorAug 08Option Exercise64.815,000324,05010,838Aug 08 07:52 PM
RUTLEDGE WILLIAM PDirectorAug 08Sale107.205,000536,0005,838Aug 08 07:52 PM
SNELL MARK APresidentMay 06Sale103.9950,0005,199,50072,909May 09 03:44 PM
OUCHI WILLIAM GDirectorMar 04Option Exercise59.155,000295,75021,230Mar 04 05:00 PM
OUCHI WILLIAM GDirectorMar 04Sale97.735,000488,65016,230Mar 04 05:00 PM
DAVIS STEVEN DExecutive Vice PresidentMar 01Sale96.298,500818,46519,890Mar 01 07:20 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E38.59 EPS (ttm)4.50 Insider Own0.20% Shs Outstand213.40M Perf Week-0.11%
Market Cap37.03B Forward P/E16.70 EPS next Y10.39 Insider Trans-11.57% Shs Float212.29M Perf Month3.44%
Income975.00M PEG3.73 EPS next Q2.12 Inst Own84.00% Short Float1.70% Perf Quarter0.87%
Sales12.48B P/S2.97 EPS this Y34.00% Inst Trans0.02% Short Ratio3.03 Perf Half Y-0.48%
Book/sh35.74 P/B4.86 EPS next Y9.69% ROA3.80% Target Price186.33 Perf Year25.24%
Cash/sh7.35 P/C23.62 EPS next 5Y10.34% ROE12.80% 52W Range127.38 - 180.95 Perf YTD4.81%
Dividend2.92 P/FCF28.95 EPS past 5Y-3.30% ROI6.90% 52W High-4.45% Beta1.00
Dividend %1.68% Quick Ratio1.10 Sales past 5Y10.50% Gross Margin48.00% 52W Low35.73% ATR2.54
Employees50900 Current Ratio1.40 Sales Q/Q5.60% Oper. Margin11.40% RSI (14)61.23 Volatility1.22% 1.40%
OptionableYes Debt/Eq1.51 EPS Q/Q-90.10% Profit Margin7.80% Rel Volume1.02 Prev Close173.52
ShortableYes LT Debt/Eq1.38 EarningsFeb 02 BMO Payout57.60% Avg Volume1.19M Price172.90
Recom2.20 SMA202.51% SMA502.52% SMA2002.35% Volume620,902 Change-0.36%
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-07-14Upgrade Stifel Hold → Buy $153
Oct-07-14Reiterated Canaccord Genuity Hold $113 → $125
Jan-19-17 10:30AM  BECTON DICKINSON & CO Files SEC form 8-K, Entry into a Material Definitive Agreement
Jan-18-17 04:30PM  BD Announces Webcast of Annual Meeting of Shareholders PR Newswire
08:22AM  Becton, Dickinson Commercially Launches Precise WTA Kits
Jan-17-17 06:59AM  BD Launches Reagents to Simplify Single Cell Research PR Newswire
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
Jan-11-17 10:27AM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : January 11, 2017
08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
08:00AM  BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call PR Newswire
Jan-10-17 07:25AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : January 10, 2017
Jan-09-17 08:00AM  BD to Present at the 35th Annual J. P. Morgan Healthcare Conference PR Newswire
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
07:04AM  Becton Dickinson downgraded by Raymond James
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
09:05AM  Inside Becton Dickinsons Financial Guidance for 2017
08:01AM  10 Great All-Weather Stocks at Kiplinger
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 10:36AM  A Look at BDXs Recent Product Launches
09:06AM  Analyzing the BD Medical Segments Product Pipeline
07:36AM  BDs Medical Segment Performance and Growth Strategy
Jan-02-17 10:37AM  BD Lifesciencess Product Pipeline Could Boost Its Fiscal 2017 Growth
09:07AM  BD Lifesciencess Performance and Core Focus Areas
07:37AM  Becton Dickinsons Long-Term Growth Profile and Expectations
Dec-29-16 12:56PM  Unusual activity: BDX & JBLU
12:48PM  Farr: My top 10 stocks for 2017 at CNBC
Dec-23-16 11:45AM  The 10 Best Dividend Aristocrats for 2017 and Beyond
09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 10:35AM  Understanding the Key Drivers of EWs Critical Care Business Growth
Dec-15-16 06:59AM  BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics PR Newswire
Dec-12-16 06:00AM  5 Investing Ideas From Top Dividend-Stock Fund Managers at Morningstar
Dec-09-16 04:41PM  BECTON DICKINSON & CO Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
Dec-08-16 12:15PM  ETFs with exposure to Becton, Dickinson & Co. : December 8, 2016
Dec-06-16 01:00PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Dec-05-16 12:38PM  BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management PR Newswire
10:38AM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events
Dec-02-16 02:49PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-01-16 05:30PM  BD Announces Pricing of Tender Offers PR Newswire
05:05PM  BECTON DICKINSON & CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:11PM  BD Announces Early Tender Results and Upsizing of Maximum Tender Offers PR Newswire
06:59AM  BD Announces Adoption of Windows 10 'Internet of Things' for the Pyxis ES System PR Newswire
06:00AM  BD to Offer Euro-denominated Senior Unsecured Notes PR Newswire
Nov-30-16 09:22PM  Is Becton Dickinson and Co (BDX) A Good Stock To Buy Right Now? at Insider Monkey
04:02PM  Becton Dickinson Lifts Dividend by 11%
01:04PM  BECTON DICKINSON & CO Financials
Nov-29-16 08:00AM  Upgrading Our Growth Forecast for Becton, Dickinson
Nov-28-16 12:51PM  Medtronic Registers Missed Revenue Estimates Yet Again, Earnings in-Line
11:56AM  ETFs with exposure to Becton, Dickinson & Co. : November 28, 2016
Nov-25-16 08:05AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: 2016 By the Numbers : November 25, 2016
Nov-23-16 11:53AM  BECTON DICKINSON & CO Files SEC form 10-K, Annual Report
08:30AM  BD to Present at the 28th Annual Piper Jaffray Healthcare Conference PR Newswire
07:13AM  Becton, Dickinson (BDX) Announces 10.6% Dividend Increase
Nov-22-16 11:04AM  Analyzing Strykers Latest Valuation
Nov-21-16 04:15PM  BD Board Increases Dividend PR Newswire
10:04AM  How Is Stryker Moving Forward with International Growth?
Nov-17-16 10:04AM  What Analysts Recommend for MDT ahead of Its Fiscal 2Q17 Results
08:05AM  Medtronics Fiscal 2Q17 Earnings Are Expected to Witness Growth
Nov-16-16 11:56PM  [$$] Caring for a growing world means halting mother and child deaths at Financial Times
06:04PM  Medtronics Revenue Is Estimated to Rise in Fiscal 2Q17
04:04PM  How Has Medtronics Stock Performed Recently?
12:03PM  Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
Nov-15-16 08:15AM  Post Earnings Coverage as DENTSPLY Sales Surge 49% Accesswire
Nov-14-16 05:21PM  BD Announces 2016 Analyst Day And Webcast PR Newswire
12:56PM  ETFs with exposure to Becton, Dickinson & Co. : November 14, 2016
10:04AM  Portfolio Optimization Strategy Continues to Drive BDs Growth
Nov-11-16 06:04PM  What Were Becton Dickinsons 4Q16 Growth Drivers?
04:11PM  Whats behind Becton Dickinsons Strong Performance in 2016?
Nov-10-16 10:12AM  Eli Lilly and Co (LLY) Gets Dedicated Humulin R U-500 Insulin Syringe From Becton Dickinson at Insider Monkey
06:59AM  BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery PR Newswire
Nov-09-16 01:57PM  Becton Dickinson Releases New Product (BDX) at Investopedia
Nov-08-16 06:59AM  BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin PR Newswire
Nov-07-16 07:17AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : November 7, 2016
Nov-04-16 10:06AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q4, 2016 By the Numbers : November 4, 2016
Nov-03-16 11:29AM  Edited Transcript of BDX earnings conference call or presentation 3-Nov-16 12:00pm GMT
10:14AM  Becton, Dickinson (BDX) Beats on Q4 Earnings & Revenues
08:58AM  [$$] Becton Dickinson's Profit Falls on Restructuring Costs at The Wall Street Journal
08:00AM  Becton Dickinson and Co Earnings Call scheduled for 8:00 am ET today
07:29AM  Becton, Dickinson (BDX) Beats Q4 Earnings & Revenues
07:07AM  Q4 2016 Becton Dickinson and Co Earnings Release - Before Market Open
06:19AM  Becton Dickinson beats Street 4Q forecasts
06:18AM  BECTON DICKINSON & CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
06:00AM  BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance PR Newswire
Nov-02-16 02:53PM  Dividend Aristocrats in Focus Part 26: Becton, Dickinson and Co.
10:19AM  Dental Stocks' Earnings Roster for Nov 3: BDX, VWR, ACET
08:06AM  Thermo Fisher Scientific Updated Its 2016 Guidance
Nov-01-16 11:51AM  ETFs with exposure to Becton, Dickinson & Co. : November 1, 2016
11:06AM  Did Stryker Exceed Earnings Expectations in 3Q16?
11:06AM  Analyzing Thermo Fisher Scientifics Recent Stock Performance
10:15AM  Becton, Dickinson (BDX) Q4 Earnings: What's in the Cards?
Oct-31-16 06:59AM  BD MAX Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections PR Newswire
Oct-26-16 12:04PM  Becton, Dickinson and Companys 4Q16 Earnings Estimates
09:39AM  Will Becton, Dickinson and Companys Revenue Rise?
09:39AM  Analysts Recommendations ahead of BDXs Fiscal 4Q16 Earnings
Oct-24-16 11:05AM  What to Expect from Baxters 3Q16 Earnings
10:05AM  Analysts Expect Flat Revenue for Baxter in 3Q16
Oct-18-16 11:12AM  Becton Dickinson Shares Favorably Valued As It Works To Boost Earnings
Oct-17-16 02:04PM  What to Expect from Abbott Laboratories 3Q16 Earnings
Oct-14-16 11:50AM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : September 09th, 2016 (record date) : By the numbers : October 14, 2016
Oct-12-16 08:52AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : October 12, 2016
Oct-10-16 09:30AM  ETFs with exposure to Becton, Dickinson & Co. : October 10, 2016
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM
Sichak StephenExecutive Vice PresidentDec 05Sale164.442,632432,8067,953Dec 06 01:48 PM
Sichak StephenExecutive Vice PresidentNov 04Option Exercise76.1818,2461,389,98026,892Nov 07 08:52 AM
Sichak StephenExecutive Vice PresidentNov 04Sale176.1010,3521,822,9878,646Nov 07 08:52 AM
Tharby Linda MExecutive Vice PresidentSep 06Option Exercise75.0120,2911,521,95722,146Sep 07 09:17 AM
Tharby Linda MExecutive Vice PresidentSep 06Sale177.2711,7042,074,8259,188Sep 07 09:17 AM
COHEN GARY MExecutive Vice PresidentAug 11Option Exercise76.6451,8333,972,481125,870Aug 12 09:40 AM
COHEN GARY MExecutive Vice PresidentAug 11Sale176.8129,3675,192,37974,037Aug 12 09:40 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Option Exercise76.183,500266,6306,758Jun 14 10:03 AM
Gallagher John EVP, Corp Finance and TreasurerJun 13Sale169.871,931328,0193,258Jun 14 10:03 AM
Shabshab NabilExecutive Vice PresidentJun 07Option Exercise74.219,055671,97811,363Jun 08 09:35 AM
Shabshab NabilExecutive Vice PresidentJun 07Sale168.755,080857,2506,700Jun 08 09:35 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Option Exercise76.2263,2004,817,38660,932May 18 09:37 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 17Sale166.2734,3735,715,19923,734May 18 09:37 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Option Exercise68.6064,5444,427,900207,225May 16 11:39 AM
Sichak StephenExecutive Vice PresidentMay 13Option Exercise72.1222,9151,652,63031,561May 16 10:56 AM
Sichak StephenExecutive Vice PresidentMay 13Sale166.4812,9952,163,4088,646May 16 10:56 AM
FORLENZA VINCENT AChairman, CEO and PresidentMay 13Sale166.1737,9336,303,327172,681May 16 11:39 AM
ORR JAMES FDirectorMay 10Sale167.661,368229,35923,045May 11 09:13 AM
Conroy AlexandreExecutive Vice PresidentMay 09Option Exercise71.8019,8111,422,36835,738May 10 02:26 PM
Lim James CExecutive Vice PresidentMay 09Sale165.605,257870,55912,556May 10 10:48 AM
Conroy AlexandreExecutive Vice PresidentMay 09Sale165.5811,2381,860,78825,611May 10 02:26 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Option Exercise74.3613,256985,65313,087May 09 04:52 PM
Polen Thomas E JrExecutive Vice PresidentMay 06Sale163.907,2421,186,9645,789May 09 04:52 PM
RIMEL REBECCA WDirectorMay 06Sale163.69684111,9646,835May 09 04:02 PM
Hurwitz Jerome VExecutive Vice PresidentMay 06Sale163.583,878634,3633,027May 09 03:54 PM
Strahlman Ellen RSenior Vice PresidentMay 06Sale163.523,019493,6677,218May 09 03:44 PM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E27.84 EPS (ttm)7.40 Insider Own0.20% Shs Outstand150.81M Perf Week1.24%
Market Cap31.07B Forward P/E19.09 EPS next Y10.79 Insider Trans0.00% Shs Float148.36M Perf Month0.32%
Income1.12B PEG2.07 EPS next Q2.05 Inst Own93.70% Short Float1.09% Perf Quarter19.06%
Sales54.86B P/S0.57 EPS this Y14.70% Inst Trans0.04% Short Ratio1.08 Perf Half Y30.44%
Book/sh75.53 P/B2.73 EPS next Y13.48% ROA4.10% Target Price223.85 Perf Year25.83%
Cash/sh44.88 P/C4.59 EPS next 5Y13.42% ROE10.40% 52W Range149.54 - 217.49 Perf YTD1.11%
Dividend1.16 P/FCF7.16 EPS past 5Y5.50% ROI9.90% 52W High-6.45% Beta0.89
Dividend %0.56% Quick Ratio- Sales past 5Y10.10% Gross Margin- 52W Low36.06% ATR4.16
Employees50100 Current Ratio- Sales Q/Q2.50% Oper. Margin4.50% RSI (14)51.53 Volatility2.01% 2.02%
OptionableYes Debt/Eq0.38 EPS Q/Q42.90% Profit Margin2.00% Rel Volume1.51 Prev Close206.00
ShortableYes LT Debt/Eq0.34 EarningsFeb 03 BMO Payout15.50% Avg Volume1.49M Price203.46
Recom2.00 SMA200.43% SMA500.71% SMA20012.21% Volume1,146,082 Change-1.23%
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Downgrade Cantor Fitzgerald Buy → Hold
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Nov-10-16Upgrade JP Morgan Neutral → Overweight
Oct-13-16Reiterated RBC Capital Mkts Sector Perform $222 → $217
Jul-22-16Reiterated RBC Capital Mkts Outperform $220 → $224
Jul-22-16Reiterated FBR Capital Mkt Perform $220 → $170
Jul-18-16Upgrade Jefferies Hold → Buy $210
Jul-08-16Downgrade JP Morgan Overweight → Neutral $196 → $150
May-05-16Reiterated Stifel Buy $209 → $220
May-05-16Reiterated RBC Capital Mkts Sector Perform $209 → $220
Dec-16-15Initiated Credit Suisse Neutral
Nov-09-15Reiterated RBC Capital Mkts Sector Perform $223 → $215
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Reiterated RBC Capital Mkts Sector Perform $230 → $223
Jul-30-15Reiterated Barclays Equal Weight $180 → $193
Jul-07-15Reiterated FBR Capital Mkt Perform $150 → $230
Jul-07-15Downgrade Argus Buy → Hold
Jul-06-15Downgrade Wedbush Outperform → Neutral
Jul-02-15Reiterated Argus Buy $180 → $220
Jan-20-17 12:13PM  UnitedHealth, Aetna and Humana May Benefit From Obamacare Repeal
Jan-19-17 11:30AM  Three Wisconsin Employers Receive Humanas Total Health Thriving Together Award for Building Culture of Health and Well-being for Employees Business Wire
Jan-18-17 10:09AM  Everything You Need To Know About Aetna And Human's Pending Merger
Jan-17-17 01:30PM  Partners in Primary Care Adds On-Site Retail Pharmacies in Greenville Area to Improve Patient Experience Business Wire
09:41AM  The Fate Of Humana Rests In The Hands Of A Federal Judge
09:02AM  UnitedHealth Earnings Beat As ObamaCare Exchange Costs Improve
Jan-16-17 06:03PM  5 Reasons to Buy Magellan Health (MGLN) Stock Right Now
Jan-11-17 05:42PM  Humana: A healthy stock?
08:27AM  Health Insurers Are Riding High -- Which Should You Buy?
Jan-09-17 08:10PM  Humana Stock Trades Ex-Dividend Tuesday at Investopedia
06:46AM  How repealing Obamacare will be Trumps Iraq at MarketWatch
Jan-05-17 06:18PM  5 Stocks That Have Gotten Cheaper in Market's All-Time High
Jan-04-17 09:30AM  Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day
08:29AM  Coverage initiated on Humana by Piper Jaffray
Jan-03-17 02:29PM  Trump's Obamacare Tweets Just Crushed These 3 Health Insurers
Jan-01-17 02:18PM  In an Ironic Twist, Obamacare Enrollment Hits an All-Time High at Motley Fool
Dec-30-16 07:07PM  [$$] Aetna, Humana Defend Merger as Justice Department Warns It Would Harm Consumers at The Wall Street Journal
06:12PM  Aetna Fight for Humana Awaits Judges Ruling in U.S. Case at Bloomberg
06:12PM  Aetna Fight for Humana Awaits Court Ruling in U.S. Merger Case
09:21AM  3 HMO Stocks to Consider as Aetna (AET) Falls Out of Favor
Dec-29-16 02:33PM  Why health insurers wont cover this $300,000-a-year rare disease drug at MarketWatch
Dec-28-16 09:16AM  Trump, GOP Face Huge 'Now What?' ObamaCare Moment
Dec-27-16 01:15PM  Aetna-Humana trial wraps up; decision expected in January at bizjournals.com
08:58AM  Aetna Continues to Grow Business, Merger Remains Uncertain
Dec-22-16 08:45PM  Humana and Aetna have a bit more time to get their deal done at bizjournals.com
07:27AM  HUMANA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
07:00AM  Health Care Uncertainty in a Trump Presidency
Dec-20-16 06:04PM  Why UnitedHealth (UNH) Stands Tall Amid All the Noise
07:28AM  Will You Hold Humana (HUM) Amid Aetna Merger Uncertainty?
Dec-19-16 04:23PM  WellCare Health Sees 2017 Earnings Below Views
Dec-16-16 06:44PM  President Touts Record Obamacare Enrollment As GOP Weighs Repeal at Forbes
11:05AM  The Only Way For TrumpCare To Be 'Terrific'
10:20AM  Jefferies 2017 Managed Care Stocks to Buy as Obamacare May Be Repealed at 24/7 Wall St.
09:30AM  Zacks.com featured highlights: Nxstage Medical, Humana, Motorola Solutions, Evercore Partners and NTN Buzztime
08:02AM  UnitedHealth's Upcoming Note Issuance Rated by A.M Best
Dec-15-16 09:56AM  Ensign Group's Unit Sells Urgent Care Assets to MultiCare
08:50AM  Molina: ACA Repeal Plans a Threat, Buyout Deals on Track
Dec-14-16 04:17PM  Anthem, Humana, United Push Back On Sarepta's FDA-Approved DMD Drug
04:14PM  [$$] Stech's Take: Cardiology Case Raises Medicare Questions at The Wall Street Journal
01:45PM  Humana Simplifies Clinical Quality Metrics to Ease Growing Reporting Demands Placed on Physicians Business Wire
12:25AM  [$$] Aetna Executives Defend Pulling Out of Some ACA Exchanges at The Wall Street Journal
Dec-13-16 11:50AM  Aetna CEO: Withdrawal from exchanges driven by business, not antitrust concerns over Humana deal at bizjournals.com
09:05AM  Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'
Dec-12-16 05:41PM  [$$] Aetna Executives Defend Pulling Out of Some ACA Exchanges at The Wall Street Journal
02:15PM  U.S. seeks to undercut Aetna CEO's defense in merger fight Reuters
Dec-11-16 02:18PM  Surprise! Some Large Insurers Actually Made Money on Their Obamacare Plans at Motley Fool
Dec-10-16 09:38AM  Why Trump And The GOP Must Replace ObamaCare Now, In 2 Charts
Dec-09-16 08:16PM  Aetna CEO Denies Obamacare Pullout Driven by U.S. Merger Suit at Bloomberg
08:05PM  Aetna CEO defends merger with Humana in antitrust trial Reuters
05:02PM  Walgreens May Be Close To Store Divestitures In Rite Aid Deal at Forbes
10:25AM  Stock Market News for December 09, 2016
07:44AM  Humana (HUM) to Write off Receivables; Updates Guidance
12:13AM  In Antitrust Trial, Justice Department Questions Aetna-Humana Asset Sale Plan at The Wall Street Journal
Dec-08-16 05:12PM  HUMANA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:00PM  Humana Writes Off Risk Corridor Receivables Business Wire
04:35PM  In Antitrust Trial, Justice Department Questions Aetna-Humana Asset Sale Plan at The Wall Street Journal
09:09AM  Humana, FullWell to Enhance Value-Based Care in Colorado
Dec-07-16 01:00PM  FullWell Enters into New Value-Based Agreement with Humana in Colorado Business Wire
10:05AM  Will Trump Era Mean Disaster for Health Insurers?
Dec-06-16 02:15PM  Humana Tops Inaugural JUST 100 List in Health Care Providers and Services Sector, Published by JUST Capital and Forbes Business Wire
09:31AM  DOJ, Aetna Lawyers Preview Their Upcoming Duel Over Planned Sale to Molina
08:08AM  Early movers: AMZN, AZN, AZO, F, MCD, AAPL, TOL, AET & more at CNBC
08:02AM  If Paul Ryan Privatizes Medicare, Aetna-Humana Trial Looms Larger at Forbes
07:05AM  Lawyer in Humana-Aetna case: Government arguing about 'a pretend world' at bizjournals.com
12:09AM  [$$] Aetna and Humana Defend Merger, as Antitrust Trial Begins at The Wall Street Journal
Dec-05-16 06:19PM  U.S. attorneys argue Aetna-Humana deal violates antitrust law Reuters
05:00PM  Trial Begins in DoJ Bid to Block Aetna/Humana Merger (AET, HUM) at Investopedia
04:45PM  In Case You Missed It Monday: Markets Shrug at Italy Vote, Amazon Goes AI
04:35PM  The Biggest Loser: Aetna Slumps 3% at Barrons.com
04:24PM  [$$] Aetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins at The Wall Street Journal
04:10PM  UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump
02:40PM  U.S. attorney argues Aetna-Humana deal violates antitrust law: trial Reuters
01:30PM  Read the statement: American Medical Association president opposes Aetna-Humana merger at bizjournals.com
11:20AM  U.S. attorneys argue Aetna-Humana deal violates antitrust law - Trial Reuters
09:03AM  Next Up: Aetna Defends Its $37 Billion Bid for Humana
05:00AM  Aetnas Remedy to Salvage Humana Deal Draws Fire From U.S. at Bloomberg
Dec-04-16 11:12PM  Aetna-Humana antitrust trial to hinge on Medicare market at CNBC
06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
02:18PM  This Trump Appointment Likely Spells Imminent Doom for Obamacare at Motley Fool
02:02PM  Billionaire Dan Loeb Buys Back Into Apple, Adds Alibaba, Visa, More at Insider Monkey
Dec-03-16 07:22AM  3 Popular Stocks Hedge Fund Tycoons Are Ditching at Motley Fool
Dec-02-16 09:05AM  To Fix Obamacare, Double Down On Population Health at Forbes
08:56AM  WellCare Health Plans (WCG) and Unit Receive Rating Action
Dec-01-16 09:22AM  Is Humana Inc (HUM) A Good Stock To Buy Right Now? at Insider Monkey
09:14AM  How investors are playing health care
07:59AM  These 4 Health Insurers Could Gain on Obamacare Repeal
Nov-29-16 11:17PM  Asian stocks mixed as markets await OPEC meeting results
02:42PM  Nasdaq At New High; UnitedHealth, Other Medicals Lead Market
01:45PM  New Go365 Wellness Program Rewards Humana Medicare Advantage Members who Pursue Better Health Business Wire
12:40PM  Aetna calls Obamacare argument in Humana merger case a 'sideshow' at bizjournals.com
09:30AM  Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
09:12AM  Humana Partners DaVita Unit to Enhance MA Plans in Florida
Nov-28-16 04:45PM  UnitedHealth Offers Bullish 2017 Guidance; Stock Rises Late
03:50PM  Anthem-Cigna Deal Seen by U.S. Economist as Risk to Competition at Bloomberg
01:35PM  Humana to Add JSA Medical Groups New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Florida Medicare Advantage Plan Networks Business Wire
Nov-27-16 10:35PM  Playgrounds for an Aging Population at The Wall Street Journal
02:18PM  This Should Be Trump's Top Priority as President, New Survey Shows at Motley Fool
Nov-26-16 10:46PM  The Astounding Thing About Donald Trump's Plan to Change Medicare at Motley Fool
Nov-25-16 08:35AM  Will Regulations Hurt Universal Health's Growth Prospects?
Nov-23-16 06:43PM  Hedge Funds Are Freaking Out Over NXP Semiconductors NV (NXPI) at Insider Monkey
Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare, and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only, and health and wellness products to employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2015, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.2 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerJan 06Option Exercise0.0014,827015,542Jan 10 01:48 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsDec 22Option Exercise123.7611,7491,454,10328,432Dec 23 01:11 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerDec 20Option Exercise81.808,500695,25813,760Dec 22 09:57 AM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerDec 15Option Exercise0.001,09205,811Dec 19 03:31 PM
LeClaire Brian P.SVP & Chief Information Off.Dec 15Option Exercise0.001,092018,393Dec 19 03:21 PM
Kane Brian ASVP & Chief Financial OfficerDec 15Option Exercise0.001,53901,539Dec 19 03:16 PM
MURRAY JAMES EEVP & COODec 15Option Exercise0.002,383060,621Dec 19 02:53 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsDec 15Option Exercise0.001,092017,220Dec 19 02:41 PM
BILNEY JODY LSVP & Chief Consumer OfficerDec 15Option Exercise0.001,539018,687Dec 19 02:14 PM
Christopher M TodoroffSr. VP and General CounselDec 15Option Exercise0.001,539014,179Dec 19 01:57 PM
BROUSSARD BRUCE DPresident & CEODec 15Option Exercise0.008,6890106,113Dec 19 01:40 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerDec 15Option Exercise0.001,09201,092Dec 19 01:14 PM
KAY CHRISTOPHER ESVP & Chief Innovation OfficerDec 15Option Exercise0.001,09201,092Dec 19 01:03 PM
Huval Timothy S.Senior VP & Chief HR OfficerDec 15Option Exercise0.001,539032,277Dec 19 12:49 PM
Zipperle Cynthia HVice President, CAO,ControllerDec 15Option Exercise0.0079404,235Dec 19 12:24 PM
BILNEY JODY LSVP & Chief Consumer OfficerDec 02Option Exercise76.4314,8681,136,36125,916Dec 05 01:38 PM
MURRAY JAMES EEVP & COODec 01Option Exercise81.0928,9892,350,58477,681Dec 02 05:36 PM
Huval Timothy S.Senior VP & Chief HR OfficerNov 11Option Exercise103.0031,1023,203,35653,344Nov 15 02:08 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerJun 17Option Exercise0.007,94707,947Jun 20 05:10 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 25Sale176.1118332,22717,301Feb 29 11:55 AM
Zipperle Cynthia HVice President, CAO,ControllerFeb 20Option Exercise0.002,92704,483Feb 22 06:41 PM
Christopher M TodoroffSr. VP and General CounselFeb 20Option Exercise0.0019,090033,989Feb 22 06:39 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 20Option Exercise0.009,192021,157Feb 22 06:34 PM
MURRAY JAMES EEVP & COOFeb 20Option Exercise0.0028,281088,936Feb 22 06:32 PM
Huval Timothy S.Senior VP & Chief HR OfficerFeb 20Option Exercise0.0019,090030,859Feb 22 06:29 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsFeb 20Option Exercise0.006,363018,382Feb 22 06:28 PM
BROUSSARD BRUCE DPresident & CEOFeb 20Option Exercise0.0070,7030131,413Feb 22 06:26 PM
AR Antero Resources Corporation daily Stock Chart
AR [NYSE]
Antero Resources Corporation